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Abstracts 
Background: Loss of laryngeal function severely affects the quality of life. To date, 
there are no optimised implants for laryngeal replacement or reconstruction; hence, it is still 
considered an unmet clinical need. The aim of this research is to develop a 3D scaffold made 
from POSS-PCU materials. This scaffold could then be assessed the biocompatibility with 
human primary bronchial epithelial cells (HBEC) and bone-marrow mesenchymal stem cells 
(BM-MSC) to produce tissue-engineered artificial larynx. 
Methods: 3D laryngeal scaffolds were fabricated from polyhedral oligomeric 
silsesquioxane – poly(carbonate-urea)urethane (POSS-PCU). The scaffolds were designed to 
be microporous with sodium bicarbonate (NaHCO3) particle size of 25 - 40 µm at different 
concentrations. This procedure created an interconnected microporous network and can be 
coated on the outer surface of casted POSS-PCU to create the 3D laryngeal frameworks. The 
materials were fully characterised and optimised for biocompatibility and voice function. 
HBEC and BM-MSC were seeded onto scaffolds and observed the viability as well as the 
characteristics after differentiation on the material such as morphology, and specific protein 
expressions via staining. 
Results: Comparison studies of mechanical strength showed no significant difference 
between porcine epithelial tissue and microporous POSS-PCU (P > 0.05), while the 
mechanical strength of the non-porous POSS-PCU was higher than the microporous samples 
and native epithelial tissue and cartilage (P < 0.05). The microporous POSS-PCU also 
responded to the air flow and generated the oscillating sound wave with the energy and 
fundamental frequency similar to the human range. Wettability analysis demonstrated the 
significant reduction in contact angle (θo) of the material after ethanol rinse (P < 0.05) which 
was similar to the commercial tissue-culture treated plastics (74°±3.32, P > 0.05). The 
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material also showed the significant protein adsorption and enhanced cell attachment and 
growth in all samples with ethanol rinse. Primary HBEC and BM-MSC had significant 
growth on 3D porous scaffolds over 14 days (P < 0.05). Furthermore, the scaffold supported 
the differentiation of primary HBECs using air-liquid interface culture to develop mature 
epithelial cells with pseudostratified layer and migration into the POSS-PCU materials. SEM 
and immunofluorescence staining revealed the specific epithelial characteristics which were 
keratin 5 in the basal layer, keratin 18 on the top layer, epithelial tight junction, ciliated cells 
and mucin5AC production. BM-MSC also presented the growth and the differentiation on 
the material. Chondrogenic lineage properties had been observed through the change in cell 
morphology and the increased production of cartilaginous-like ECM such as sulphated-
glycosaminoglycan (sGAG) and collagen. 
Conclusion: It had been demonstrated that the 3D scaffold made from POSS-PCU 
promotes cell adhesion, proliferation and differentiation with mature epithelial features as 
well as chondrogenic properties. This scaffold holds great promise to develop a tissue-
engineer-based larynx for laryngotracheal replacements. 
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Chapter 1 Introduction 
Currently, there is no ideal surgical or prosthetic solution for patients with the irreversible 
laryngeal disease. Total laryngectomy is still the most common surgical option available for 
serious trauma which negatively impacts the patient’s quality of life[1,2]. The impacts were 
not so much because of the loss of voice and speech capabilities, but rather the exposed 
tracheostomy, that influences social consequences and quality of life[3–5]. The most 
significant impacts are the change of patient’s self-image, a deteriorated relationship with 
their partners, reduced sexuality, and increased social isolation[2]. Moreover, some reports 
conclude that a tracheostomy has a destructive influence on postoperative modification and it 
may have more impact on quality of life than loss of voice[6]. To date, laryngectomy is the 
only possible therapeutic option available for patients with advanced laryngeal trauma[7].  
The treatment for patients with total laryngectomies has not been changed for decades. 
Laryngeal replacement with donor’s organ was done successfully. However, the risk of 
chronically immunogenic rejection may present later on[8,9]. Many approaches are 
employed to develop substitute materials to improve the treatment, especially the biomaterial 
manufacture and tissue engineering. Because the architecture of the larynx is complicated, 
which consists of epithelium, muscles and cartilages as a framework, the main issue is how 
to construct the larynx with the bioartificial 3D structures with low immunogenicity[10]. 
Thus, the development of total laryngeal replacement devices is aiming at the functional 
prosthesis with tissue regeneration, and the considerable increasing quality of life of patients. 
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1.1 Anatomy and the physiology of the larynx 
The human respiratory system lines across the digestive tract in the area known as the 
pharynx. By sharing a common passageway with the upper digestive system, the larynx 
serves three importantly major functions, 1) respiration, 2) protection and 3) phonation[11–
13]. The larynx connects to the upper (pharynx and nose) and lower airways (trachea and 
lungs) essential for respiration. The protective mechanism is initiated when the larynx is 
elevated, and the flap-like epiglottis closes the airway, which results in food travelling into 
the oesophagus during swallowing. The larynx also provides the basic phonatory sounds 
upon the adduction of the vocal cords. When the air passes from the lungs to the pharynx, the 
vocal folds consequently move together to close the glottis (adduction) and cause the rise in 
subglottic pressure that push the vocal folds to vibrate. This cycle is repeated to produce 
vibrations and hence a multitude of different sound frequencies[14–16]. 
The larynx (Figure 1.1) is composed of cartilaginous structures that protect the glottis, 
which is the small opening that lets in the air as it passes through in to the lungs. The 
structure is divided into three unpaired cartilage tissues; namely, the thyroid cartilage, 
cricoid cartilage and epiglottis, which forms the structure of the lateral wall of the larynx. It 
also consists of smaller paired cartilage structures namely the arytenoid, corniculate and 
cuneiform cartilages. The smaller cartilages together with the ligaments mostly involve the 
opening and closure of the vocal folds. The biomechanical properties of the vocal folds 
depend on its unique layers of squamous epithelium, the lamina propria and the vocalis 
muscle[17]. The superficial layer of lamina propria combined with epithelium is also known 
as the mucosa. The lamina propria is composed of extracellular components, which consist 
of elastic and collagen fibres, glycosaminoglycans, glycoproteins, minerals and 
water[17,18]. 
21 
 
  
 
Figure 1.1 Anatomy of human larynx, showing the structure of cartilage, muscle, and vocal 
cords. 
1.2 Laryngeal diseases and treatment   
Many stimuli can lead to the larynx malfunction and damage, including excessive 
mechanical stress, smoke inhalation, vital accidents and cancers[19]. The larynx is the 
second most common site for head and neck cancer which is globally the sixth most common 
cancer[20,21]. In 2008, an estimated 635,000 new patients with head and neck cancers were 
diagnosed, including 47,500 cases in the United States and 95,500 in Europe[22]. In 2012, 
13,510 new cases of pharyngeal cancer and 12,360 new cases of laryngeal cancer were 
diagnosed in the United States (http://www.cancer.gov).  
Total Laryngectomy is the surgical procedure of removing the larynx and separating the 
airway from the mouth, nose and oesophagus, and still plays an important role in primary 
therapy for advanced stage laryngeal cancer[23].  Subsequently, the laryngectomee will 
breathe through an opening in the neck known as a stoma[24]. This procedure is usually 
performed in cases of laryngeal cancer and also on individuals with other types of head and 
neck cancer[25]. 
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Apart from laryngeal damage, the congenital disorder is one of the reasons that require 
later laryngeal reconstruction. Most of the cases could be treated with microsurgery; 
however, in some cases require the material postoperatively to maintain or reconstruct the 
laryngotracheal cavity[26]. Reports have shown patients with laryngotracheal stenoses went 
through the laser surgery[27] and were usually reconstructed and dilated their airways with 
Montgomery silicone tube[28]. Recently, advanced materials have played an important role 
and pave the way for the development of laryngotracheal replacements in the clinic, 
especially for the case that has high complications. These include stem-cell-based 
decellularised tissues[29], stem-cell-seeded nanocomposite POSS-PCU[30], Marlex-mesh 
tube coated with collagen sponge[31], and titanium tube with solid and porous parts[2]. The 
objectives of these developed materials are using the regenerative medicine approach to 
improving the efficacy and sustainable healing with restoration of organ’s function. 
1.3 Regenerative medicine approaches for laryngotracheal 
applications 
Regenerative medicine is currently the research field combining tissue engineering and 
stem cells to create improved personalised treatment for patients. The immense progress of 
these studies is advanced and some of them have gone to clinical trials. The two main fields 
being developed for laryngotracheal tissue engineering application include biomaterials, act 
as a scaffold for tissue regeneration, and stem cell mediation, for improved tissue 
regeneration and wound healing process. The concept for laryngotracheal regenerative 
medicine is shown in Figure 1.2. 
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Figure 1.2 A schematic shows laryngotracheal regenerative medicine concept. The primary 
bronchial epithelial cells (i) and stem cells, e.g., BM-MSCs (ii) are extracted from the 
patient. Cells are expanded with induced growth supplement in a laboratory (iii). Cells are 
seeded onto biomaterial scaffold (iv), and the cell-scaffold construct is implanted back to the 
patient with functionality (v). 
1.3.1 Biomaterials for tissue engineering 
In recent years, there has been the considerable progress of research based on tissue-
engineering approach including finding new materials, incorporation of growth factors, and 
particular cell seeding, to enhance the survival of the graft. Regarding the materials, they are 
usually divided into two types, natural-derived scaffolds (i.e., autologous, allogeneic, or 
xenogeneic donor tissue source) and synthetic scaffolds (i.e., metal or plastic polymer). 
Much debate surrounds whether to use natural- derived scaffolds, which aim to preserve the 
major components of the extracellular matrix (ECM) through a process known as 
decellularisation, or synthetic scaffolds which are easier to control the manufacture. The 
main differences between natural and synthetic scaffolds are summarised in Table 1.1. 
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Table 1.1 Differences between natural and synthetic scaffolds for laryngotracheal 
applications, published by Fishman, et al[32]. 
Natural Synthetic 
Biological scaffolds composed of ECM, mimics native 
tissue and can accommodate cell growth 
Artificial material 
Contain donor antigens: decellularisation makes them 
non-immunogenic 
More likely to cause a foreign body reaction when 
implanted into the body 
Better biocompatibility Biocompatibility depends on material 
Excellent tissue microarchitecture Microarchitecture does not resemble tissue it is being 
used to replace 
Excellent bioactivity if ECM components and growth 
factors preserved 
Bioactivity depends on material 
Preserved microvasculature Absent vasculature 
Less control over biodegradation properties Biodegradation and porosity can be controlled to some 
extent 
Biomecahnical properties depend on material Biomechanical properties can be controlled 
Possibility of microbial contamination during 
preparation and storage 
Contamination less likely 
Requires times for harvesting and preparation (weeks). 
Supply depends on donor tissue availability 
Off-the-shelf availability 
Cheaper to manufacture More expensive to manufacture 
 
1.3.1.1 Natural-derived scaffolds 
In recent years, decellularised tissues obtained with the detergent-enzymatic method, 
have increased the evidence that they are non-immunogenic, and can be used as scaffolds to 
promote in vivo in-growth of host cells and tissue[33,34]. Scaffolds derived from 
decellualrised tissues have been used successfully in both pre-clinical animal studies and 
human clinical trials, without the formation of anti-HLA antibodies[35–37].  
The donated tissues are usually degraded by cellular enzymatic activity through 
proteolysis, hence releasing growth factors and peptides that could stimulate constructive 
tissue remodelling are now in great demand[7]. These proteins serve many functions, namely 
structural supports, development of angiogenesis and vascularisation, cell migration, 
proliferation and subsequent tissue growth[38].  
Natural ECM from donor tissues can be processed using surfactants and enzyme 
degradation steps that get rid of native cells, and antigens to leave 3D scaffolds composed of 
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natural ECM tissue for new cell growth and create adequate compatibility, and a minimal 
tissue response with the recipients’ host immune system. The material could be obtained 
from various sources, such as decellularised autogenic, allergenic or xenogenic grafts. 
Porcine urinary-bladder submucosa-layer was used as decellularised ECM for laryngeal 
reconstruction in canine models[39]. The vocal cords were removed and thyroid cartilage 
was replaced with urinary bladder submucosa ECM, and presented a simple squamous 
epithelial lining, organised glandular structure within the submucosa and thyroid cartilage 
and bundles of skeletal muscle three months after surgery. 
An acellular xenogenic ECM substitution was developed using the vocal fold lamina 
propria from bovine sources and seeded with human vocal fold fibroblasts to examine the 
biochemical properties and biocompatibility[40]. The results showed that the scaffold was 
repopulated with cells with greatly improved biomechanical properties of the 3D structure 
and production of active proteins such as hyaluronic acid and decorin. Further research was 
carried out in a rat model using the same material[41]. The results demonstrated significant 
cellular infiltration into the scaffold following implantation in the acute stages of wound 
repair (day 3 to 10 post surgery). Also, the key ECM proteins were higher in the acute stage 
than those of the controls, indicating ECM remodelling by the host fibroblasts. However, the 
implanted scaffolds were found to be completely degraded by Month 3. Moreover, a whole 
laryngeal allograft was also performed in rabbits in 2011[42]. The larynges connected to the 
upper part of trachea was removed and perfused with enzymatic reagents through the carotid 
arteries. The larynges were then recellularised with mesenchymal stem cells (MSCs) from 
bone marrow from rabbits and implanted in the greater omentum. After 8 weeks of 
implantation, the recellularised larynx was dissected and the laryngeal framework remained 
intact and well integrated with muscle tissue and vascularisation was also apparent. 
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The potential replacement by decellularised larynx has become feasible when human 
cadaveric larynges were used in decellularisation of 25 consecutive cycles of the detergent-
enzymatic method (DEM)[7]. The study revealed the success of decellularisation removing 
all cells, nuclear debris and materials from the ECM. The procedure preserved not only ECM 
structural components necessary for cell proliferation, but also ECM proteins that have an 
impact on angiogenesis. Although natural scaffolds tend to facilitate tissue repair, the 
method of its preparation can dramatically alter the biomechanical properties of the resulting 
scaffold, compromising its ability to provide mechanical support during the remodelling 
process, as well as, affecting the host remodelling response of the tissues. 
Long-segment congenital tracheal stenosis and pulmonary sling in a 12-year-old boy had 
been replaced with a decellularised cadaveric donor tracheal scaffold seeded with BM-MSCs 
and patches of autologous epithelium[43]. The graft vascularised within 1 week after surgery 
but the cytological indication of epithelium restoration did not present until 1 year. The graft 
did not have mechanical strength focally until 18 months; however, the patient did not need 
any further medical intervention. Eighteen months after surgery, he had a regular chest CT 
scan and ventilation-perfusion scan. At 2 years follow-up, he had a functional airway and 
had returned to school. 
1.3.1.2 Synthetic scaffolds 
Several synthetic scaffolds have been investigated for larynx reconstruction over the past 
decade. The following are examples of scaffolds made of effective materials developed so 
far, which have been mainly applied to pre-clinical studies. A clinical challenge has 
remained in the development of the materials with few reliable options available. 
Laryngotracheal treatments have been focused on injectable fillers, implantable 3D 
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materials, or cell therapy with the aim of restoring the normal biomechanical function of the 
organ[44].  
1.3.1.2.1 Hydrogels 
The lamina propria of vocal folds is a multi-layered connective tissue, which is mainly 
composed of fibroblasts, and their ECM structures containing elastin, collagen, hyaluronic 
acid, and proteoglycans[45]. When the composition of ECM of the lamina propria changed, 
the vocal fold vibratory function can be severely impaired and interrupted due to 
modifications in tissue viscoelasticity[46]. Hydrogels have become promising materials to 
treat specific symptoms like vocal fold scar and fibrosis since the materials are known to 
influence cell-cell and cell-matrix interactions[47]. Human vocal fold fibroblasts (VFFs) 
encapsulated within the hydrogel matrices expressed genes related to several ECM 
proteins[19]. Biocompatibility was evaluated in human VFFs cultured in 3D Carbylan GSX 
(A disulphide cross-linked hydrogel of hyaluronan and gelatin, used as an extracellular 
matrix), and was compared with commercially available Matrigel™ (Corning, 
Massachusetts, USA). There was no significant difference regarding viability, and marker 
protein expression of human VFFs cultured with Carbylan GSX compared to Matrigel™ 
after 1 week. Also, cytokine IL6 and IL8, ECM (COL1) and hyaluronic acid synthase 3 gene 
expression levels decreased when cultured in Carbylan GSX demonstrating that Carbylan 
GSX may be suitable for tissue engineering and reconstruction of human vocal folds[46]. 
Five different hydrogels (hyaluronic acid, collagen, fibrin, and co-hydrogels composed of 
fibrin-collagen and fibrin-HA) were used under defined experiment conditions, which 
controlled the differentiation of adipose-derived stem cells into the functional equivalent of 
VFFs. The cells cultured in the co-hydrogels show stellate and elongated morphology, 
expressed decorin and elastin and produced glycosaminoglycan, thus enhancing 
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proliferation, differentiation and gene expression[48]. Thibeault et al. studied the utilisation 
of injectable hyaluronan hydrogels via vocal fold injection against normal saline as controls 
in a rabbit model in 2011, and found the treated vocal folds were found to be significantly 
less fibrotic than the saline controls with significantly improved viscosity and tissue 
elasticity[49]. 
1.3.1.2.2 Collagen coated polypropylene mesh 
Collagen coated polypropylene mesh has been used for laryngeal and tracheal 
reconstruction and tissue engineering applications in 2004[50]. Polypropylene mesh 
(Marlex™)  was employed as a 3D scaffold or framework for larynx, which was coated with 
collagen type I and III and cross-linked to the surface before implantation in vivo[50] or 
human patients[51]. The collagen scaffold was further investigated by culturing with bone-
marrow stromal cells (BMSCs). The material was found to support cell growth, adhesion and 
proliferation. The cell surface markers for mesodermal tissue were also positively 
identified[52]. In a canine model, regeneration of the epithelium and sub-epithelial tissue 
was also apparent[53], and also, the incorporation of the fascia lata by the wrapping of the 
scaffold around the defect was found to repair the tissue and reduce infection. In 2012, this 
material was used to create a prosthesis for cricoid repair and regeneration. The collagen 
scaffold incorporated fibroblasts to regenerate the tissue and enhance wound healing. It was 
found that after 14 days of implantation, epithelialisation and cartilage formation was 
observed throughout the scaffold[54]. 
1.3.1.2.3 Porous titanium 
Most attempts to reconstruct an artificial trachea have hardly accomplished long-term 
success[55]. Tissue integration as a result of the biomaterial itself and mechanical 
properties[56] were the main difficulties caused the rejection of the prosthesis. Titanium is a 
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metal known to be chemically resistant to the corrosive and oxidative activity of various 
agents[57]. These characteristics make titanium a widely used metal for implants, and 
especially in odontology[58].  
Porous titanium was also developed and used as an artificial tracheal prosthesis for short-
term study in rats[59]. Eleven of seventeen animals were survived throughout the experiment 
and the histologic analysis revealed fibroblast colonisation in titanium pores, a ciliary 
cylindrical epithelial layer developed on the luminal side of the prosthesis, and the 
inflammatory reaction was minimal[59]. Another study with the same material in mice and 
rabbits also showed the regeneration of mucosa with the submucosal layer on top of the 
titanium, multiple blood vessels extending from the muscle layer through the titanium, and 
expression of cytokeratin in the basal layer of the mucosal epithelium[60]. This porous 
titanium was also included in the design of artificial titanium larynx used in the clinical trial, 
with the aim of assisting the integration of patient’s proximal trachea[2]. 
1.3.1.2.4 POSS-PCU nanocomposite material  
A novel nanocomposite material has been developed at the Centre for Nanotechnology 
and Regenerative Medicine, University College London. POSS-PCU is a hybrid co-polymer, 
consisting of a crystalline hard segment and soft elastomeric segments in which polyhedral 
oligomeric silsesquioxanes (POSS) nanoparticles are attached as pendant chain functional 
groups to the backbone of poly(carbonate-urea) urethane (PCU)[61]. The POSS nanoparticle 
is one of the most promising nanomaterials for medical applications[62]
,
[63,64], consisting 
of a nanocage structure with an inner silicon frameworks and oxygen atoms, and the outer 
part of organic functional groups. 
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Figure 1.3 Schematic diagram of POSS-PCU molecular structure. The POSS nanocage with 
the size approximately of 1.5 nm with an inner silicon and oxygen frameworks, externally 
covered by organic functional groups, which are covalently bonded to PCU. The 
incorporation of POSS into PCU has resulted in an advanced nanocomposite polymer with 
unique characteristics for larynx applications. I-Bu=R, Isobutyl tertiary groups. 
The addition of the POSS-nanocage to the PCU backbone has caused an improvement in 
the construct’s overall resistance to oxidative degradation when compared to PCU alone, as 
demonstrated in a previous study where POSS-PCU was exposed to in vitro accelerate 
degradation[65]. The POSS nanoparticle was shown to enhance the PCU’s mechanical 
strength while maintaining its elasticity, making it ideal for use in vascular prostheses, 
particularly at low flow states[65]
,
[66]
,
[67]. 
POSS-PCU has been demonstrated to possess superior mechanical and viscoelastic 
behaviour compared to conventional polyurethane-based (PU) polymers and the heterograft 
tissues. It has shown a comparable hardness and tear strength to commercially available 
polymers such as Estane®, Chronoflex C®, and Elasteon™[68]. POSS-PCU has been used 
to develop surgical implants following extensive in vitro and in vivo studies to show 
enhanced degradation resistance[65], in vivo biocompatibility, and biological stability over a 
3 year period in an ovine model[69]. POSS-PCU is currently undergoing pre-clinical studies 
as heart valve replacements[68] and has been used for first-in-man studies as compassionate 
cases as a lower limb bypass graft[70] and lachrymal duct conduit[71]. The material was 
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used to develop the first synthetic trachea by incorporating the patient’s own stem cells and 
implanted successfully into a patient suffering from cancer[30]. 
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Table 1.2 Summary of materials being developed for laryngotracheal reconstruction 
Year Material Method Experiment Outcome Reference 
2012 Decellualised 
trachea 
The trachea was using detergent-
enzymetic method (DEM) previously 
published[72]. 
Clinical trial The graft revascularised with epithelial restoration after 1 year. 
The mechanical strength of the graft did not present until 18 
months, but the patient did not need any medical intervention 
since then. Eighteen months after the operation, he had a 
normal chest CT scan and ventilation-perfusion ratio. At 2 
years follow-up, he had a functional airway. 
Elliott et al.[43] 
2011 Decellularised 
larynx 
Larynges were decellularised with a 
total of 25 consecutive DEM cycles. 
In vitro Decellularisation procedure preserved not only ECM structural 
component necessary for cell proliferation but also ECM 
proteins that have an impact on angiogenesis. 
Baiguera et al.[7]  
2011 Decellularised 
larynx 
Perfusion-decellularised larynges were 
obtained from 20 rabbits by perfusion 
of the carotid arteries with 
decellularised solution. The larynges 
were seeded with myogenic-induced 
MSCs from eight receptor rabbits. The 
constructs were implanted into greater 
omentums of receptor rabbits after cell 
adherence in vitro. 
Rabbit Larynges perfused by sodium dodecyl sulphate became clear 
after 2 h of perfusion. Histology and SEM indicated almost no 
intact cells or nuclei were found while pores and collagen 
fibres were maintained in the decellularised matrix. 
Vascularization was clearly seen after 4 weeks and integrated 
cartilage frameworks remained by 8 weeks. Histological and 
immunohistochemical revealed muscles and vessels. 
Hou et al.[42] 
2010 Decellularised 
bovine vocal 
fold lamina 
propria 
Decellularised bovine lamina propria 
scaffold 
Rat After implantation of the acellular scaffold, the remodelling 
process occurred during the wound healing. Collagen I, 
Collagen III and glycosaminoglycans was significantly higher 
than those of the control after 3 days. Scaffold was degraded by 
3 months with no fibrotic tissue formation or calcification. 
Xu et al.[41]  
2007 Decellularised 
bovine vocal 
fold lamina 
propria 
 
 
 
Human vocal fold fibroblast seeded in 
decellularised bovine lamina propria 
scaffold 
In vitro Bovine vocal fold lamina propria can utilized as a 
biodegradable scaffold via decellularisation. 
Human vocal fold fibroblast demonstrated well attachment to 
the scaffold, biocompatibility, and active protein synthesis, 
especially hyaluronic acid and decorin. 
Xu et al.[40]  
2003 Porcine-
urinary 
bladder 
submucosa 
ECM 
Canine hemilaryngectomy – vocalfold 
was replaced with 1 sheet UBS-ECM 
- 4 sheet and 8-sheet fort hyroid 
cartilage in each study group. 
Canine 
 
Presence of a simple squamous epithelial lining, organized 
gradular structures within the submucosa, reconstructed thyroid 
cartilages and bundle of skeletal muscle by 3 months after 
surgery. 
  
Huber et al.[39]  
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Year Material Method Experiment Outcome Reference 
2010 Hydrogels  
 
Primary vocal fold fibroblast from 
porcine’s larynx encapsulated in 
hydrogels  
In vitro The collagen HA composite hydrogels, when properly 
formulated, are attractive candidate for prolonged 3D culture 
for PVFF. 
Farran et al.[19]  
2010 Hydrogel – 
Carbylan 
GSX 
Human vocal fold fibroblast (hVFF) 
seeded in transwell for 2D and 3D 
culture 
In vitro Carbylan GSX does not induce significant toxicity or 
inflammation. 
After 7 day-period, hVFFs were able to produce m-RNA for 
ECM constituents found in lmina propria tissue. 
Chen et al.[46]  
2010 Hydrogel  Human female adipose-derived stem 
cell (ASCs) embedded in hydrogels 
consisted of 1)Fibrin, 2)Collagen, 
3)HA, 4)Fibrin-collagen or 5)fibrin-HA 
In vitro Cells grown in the co-gels showed preferable morphology, 
expressed Decorin, and synthesised glycosaminoglycan, which 
indicate differentiation of ASC. 
Cogels of HA or collagen with fibrin enhanced cell 
proliferation and differentiation. 
Park et al.[48]  
2010 Hydrogel Isolated mouse bone-marrow 
messenchymal stemcell (BM-MSC) 
embedded in Extracel hydrogel, vocal 
fold injected  
Mouse BM-MSC grown in vitro within sECM expressed Sca-1, was 
positive for hyaluronan receptor CD44 and proliferated. 
Embedded BM-MSC in sECM presented an increase of pro-
collagen III, fibronectin and TGF-β1, downregulated SMA, but 
upregulated HYAL3 and no change in HAS3. 
 
Johnson et al.[73]  
2011 Injectable 
Hyaluronan 
derivative 
(Extracel) 
 
Inject directly to the vocal fold 
compared to saline 
Rabbit Vocal folds treated with Extracel significantly improve 
viscoelastic properties and healing with less fibrosis on ECM. 
Thibeault et al.[74]  
2009 Fibrin 
hydrogels 
Human adipose-derived stem cells 
embedded in air-gel matrix in transwell 
with EGF 10ng/mL 
or FGF10ng/mL 
 
 
In vitro Cells survived, attached and populated three dimensional fibrin 
matrices. 
Epidermal Growth Factor and air interface were required to 
produce epithelial differentiation. 
Long et al.[44]  
2006 Collagen-
alginate and 
collagen-
hyaluronan 
(HA) 
hydrogel 
 
 
 
Collagen-alginate and collagen-
hyaluronan (HA) hydrogel seeded with 
pig  vocal fold fibroblasts 
In vitro Collagen-alginate and collagen-HA hydrogel enhanced vocal 
fold fibroblasts to proliferate and synthesize GAG; however, 
collagen-alginate hydrogel was more stabilized and provided 
longer mass augmentation. 
Hahn et al.[75]  
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Year Material Method Experiment Outcome Reference 
2010 Pre-clotted 
polypropylene 
mesh coated 
with collagen 
 
 
Material was wrapped with autologous 
fascia lata 
Canine 
 
Favourable vocal fold contour was found in 4 of 5 cases.  
Histologic data revealed the regeneration of lined epithelium, 
subepithelial tissue and muscle structure in both groups. 
Yamashita et al.[53] 
2009 Terudermis, 
an 
atelocollagen 
sponge 
derived from 
calf dermis 
Bone marrow-derived stromal cells 
were obtained from GFP (green 
fluorescent protein) mouse femurs. The 
cells were seeded into Terudermis and 
incubated for 5 days. Their survival, 
proliferation, and expression of 
extracellular matrix were examined. 
In vitro Bone marrow-derived stromal cells adhered to Terudermis and 
underwent significant proliferation. Immunohistochemistry 
demonstrated that cells were positive for vimentin, desmin, and 
fibronectin, and negative for beta III tubulin. These findings 
indicated that these cells were mesodermal cells and attached to 
the atelocollagen fibres biologically. 
Ohno et al.[52] 
2008 Marlex mesh 
tube covered 
by collagen 
sponge 
In situ tissue engineering with a 
scaffold implant was applied to repair 
the larynx and trachea in 4 patients. 
Clinical trial A patient with subglottic stenosis and 3 patients with thyroid 
cancer and cricoid-tracheal tumour invasion were replaced with 
the scaffold implants. Postoperative endoscopy in a period of 8 
to 34 months presented a well-epithelialised airway lumen 
without any obstruction. 
Omori et al.[31] 
2004 Marlex mesh 
tube coated by 
collagen 
sponge 
Marlex mesh tube coated by collagen 
sponge was used for a rigid airway 
framework and for tissue regrowth 
around the tube. 
 
 
 
Canine By endoscopic investigation at 3 to 7 months, no airway 
obstruction was found in any of the dogs. There was a good 
confluent regeneration of the epithelium layer over the scaffold 
and incorporation of the scaffold mesh into the host tissue. 
Omori et al.[50] 
2014 Artificial 
larynx with 
porous 
titanium ring 
The prosthesis was formed of 2 parts of 
a tracheal prosthesis with a porous 
titanium connected with the trachea, 
which was implanted in the first step to 
ensuring tissue integration and a 
removable part composed of valves that 
enable breathing. The implant was 
observed with a nasofibroscopy of the 
lumen and CT scans. 
 
 
 
 
Clinical trial The laryngeal function of the patient in the postoperative has 
significantly improved, such as breathing and swallowing. The 
patient was able to talk with a whispering voice while the 
tracheostomy was temporarily closed. The implant's porous 
part was colonised by the proximal tissue and no fistulas were 
found as evidenced by barium swallow. 
Debry et al.[2] 
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Year Material Method Experiment Outcome Reference 
2009 Porous 
titanium 
The defects were reconstructed with 
porous titanium implants and mucosa 
using a 2-step procedure. The implants 
were investigated on angiogenesis and 
mucosal survival. 
Rabbit All animals survived after the reconstruction. The titanium 
implants were integrated to the proximal tracheal cartilage and 
surrounding tissues, supporting the regeneration of the mucosa. 
Janssen et al.[60] 
2002 Porous 
titanium 
tracheal 
prosthesis 
Seventeen rats had a partial tracheal 
reconstruction made of porous titanium. 
The histological analysis of the tissue 
was performed in 11 surviving animals. 
Rat Fibroblast colonisation into titanium pores and a ciliation of the 
cylindrical epithelial layer were observed on the endoluminal 
side of the graft. The inflammatory reaction of the rats was 
minimal. 
Schultz et al.[59] 
2011 POSS-PCU A 36-year-old male patient presented a 
primary cancer of the distal trachea and 
main bronchi. After complete tumour 
resection, the airway was replaced with 
nanocomposite tracheal scaffold 
previously seeded with autologous 
bone-marrow mononuclear cells via a 
bioreactor for 36 h. 
Clinical trial After cell reseeding and bioreactor process, there was an 
extracellular matrix-like coating and proliferating cells with a 
CD105+ subpopulation. No major complications were 
observed and the patient no complicated symptom and tumour 
free 5 months after transplantation. The nanocomposite 
scaffold integrated to anastomosis, with a vascularised 
neomucosa. These findings suggest wound repair and 
neovascularisation of the graft. 
Jungebluth et al.[30] 
2009 POSS-PCU The peptide was cross-linked to POSS-
PCU material. The contact angle was 
analysed and specificity tests were 
performed with the peptide RAD. 
Progenitor cells were extracted from 
peripheral blood and cultured on the 
porous biofunctionalised material under 
static conditions. 
In vitro Endothelialization was confirmed by SEM and immunostaining 
for endothelial cell markers. Contact angle indicated that 
biofunctionalisation had increased the hydrophilicity of the 
nanocomposite polymer. Alamar Blue assay indicated cells on 
nanocomposite scaffold and the relative increase in cell 
viability was specific to RGD samples. 
De Mel et al.[70] 
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1.3.2 Stem-cell-mediated therapy 
Many types of reseach have currently paid attention towards the potential of stem cells 
for laryngotracheal applications. The main goals are usually for 1) assisting in the 
extracellular matrix (ECM) remodelling for vocal fold scar and fibrosis, and 2) 
differentiating stem cell to substitute the primary cell sources, e.g., epithelial cells, due to its 
limited expansion ability. 
 Vocal fold scarring demonstrates therapeutic challenges by using cell therapy with stem 
cells which have become a promising approach. Treatment of adipose-derived stem cells 
(ASC) and bone marrow-derived stem cells (BM-MSC) in rats showed improved ECM of 
the vocal fold with significantly increased hyaluronic acid (HA) and reduced dense collagen 
deposition in ASC and BM-MSC groups compared to sham controls up to 3 months after 
treatment[76]. Mechanosensitivity of MSC may also respond to the dynamic mechanical 
environment of the larynx. A vibratory-strain bioreactor and gene expression study (cDNA 
microarray) were used to investigate the similarity of ASC and BM-MSC to the native cell 
source (VFF). The results demonstrated that VFF shared more gene ontology (GO) terms 
related to epithelial differentiation, ECM remodelling, growth factor activity, and immune 
response with BM-MSC than with ASC. However, GO terms relating to differentiation 
toward osteogenic, adipogenic, and chondrogenic lineages were fewer and tended to lose 
osteogenic potential in the vibrated conditions compared to the non-vibrated one[77]. 
Treatment of vocal fold scarring in rats with the injection of BM-MSC in the sECM hydrogel 
(Glycosan BioSystems, Inc., Utah, USA) presented the positive outcomes in ECM 
production, hyaluronan metabolism, myofibroblast differentiation, and production of TGF-
β1 with no detectable cytotoxicity[78]. 
Epithelial cells are crucial for airway lumen as they form the barrier, produce the mucus 
by Clara cells to trap pathogenic substance, and remove the mucus away by the harmonic 
waving of ciliated cells[79]
,
[80]. Due to their limitations in isolation and expansion, induced 
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pluripotent stem cell (iPS), is the alternative researchers are interested with aiming to cope 
with these difficulties. Imaizumi et al. had shown human iPS cultivated on hydrogel with 
human VFFs or with EGF had significantly decreased levels of pluripotency marker (Oct 
3/4). However, the epithelial-associated proteins (cytokeratin 13 and 14) expressed at 4 
weeks after cultivation with a degree of nuclear polarity, suggested that cells had changed to 
the epithelial phenotype[81]. The method to generate functional human respiratory epithelial 
cells from human iPSCs has been well established by Firth et al. using multi-step 
differntiations[82]. The differentiated cells presented relevant gene expressions, protein 
expressions and phenotype of epithelial cells.This results can provide not only unlimited 
source of cells but also the opportunity for using the cells in disease modelling or tissue 
engineering, incorporation with biomaterial scaffolds. 
1.4 Conclusion  
Unmet clinical needs of organ transplantation and shortage of organ donors required the 
world to seek for the optional treatment for patients. Many biomaterials with patient’s cell 
seeded are viable plans and had been widely in trials around the world to use in tissue 
reconstructions and organ replacements. Among them, the synthetic material has offered the 
potential in many ways to develop using tissue-engineering techniques; however, some 
issues still needs more investigation such as biocompatibility and long-term effect after 
implantation. POSS-PCU has been developed and studied on biocompatibility, in vivo 
implantation and a clinical trial in human for many applications such as bypass graft, 
lacrimal duct, and trachea. Over 10 years of extensive research on POSS-PCU material 
makes it a potential candidate to develop for laryngotracheal applications. The versatility of 
POSS-PCU fabrications make it useful in many ways, from making a 3D macro-scale of 
organ, to the interaction with cells in micro- and nano-scales. This has been the inspiration to 
use one material to serve different purposes by developing a 3D laryngeal scaffold to serve 
the transplantation of the total larynx with functionalisation including organ structure/stent, 
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voice production, and cellular mediation/regeneration. Also, the better epithelialisation and 
cartilage formation on the material might help the implant integrates to the proximal trachea 
with less chance of extrusion. Therefore, the aim of this thesis is to optimise and develop a 
manufacture of POSS-PCU 3D scaffold for laryngotracheal reconstruction with a focus on in 
vitro epithelialisation and chondrogenesis on the material. 
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Chapter 2 Aims of thesis 
The complications of laryngotracheal reconstruction with both biologic and synthetic 
implants have previously been discussed. The important aim of this thesis is to design and 
develop a clinically feasible replacement that improves upon the current available laryngeal 
implants, which have not yet fully served laryngeal functions. Multiple challenges need to be 
overcome to assist the development of such an implant. The laryngeal implant should mimic 
the mechanical properties of the human larynx, be readily available (off-the-shelf). 
Moreover, the implant also needs to interact well with the surrounding tissue (epithelium or 
cartilage), promote tissue integration and angiogenesis, and heal the inflammatory effects. 
The hypothesis of this study is that the new nanocomposite biomaterial based on POSS-PCU 
can be used as an alternative for a synthetic implant for laryngeal reconstruction. To support 
this hypothesis POSS-PCU scaffold has been used in optimization of a 3D scaffold, and 
evaluated the capability to generate epithelialisation and chondrogenesis in vitro. 
The work in this thesis can be broken down into a number of specific aims: 
1. To design and develop personalised laryngeal scaffolds based on the POSS-PCU 
material. 
- To create a novel custom-made thyroid shape scaffold 
- To investigate the using of the solvent evaporation and phase 
inversion(coagulation)/particulate leaching techniques for 3D scaffold fabrication 
- To evaluate the mechanical properties of the material, matching to the porcine larynx 
(for future in vivo work) 
- To set up the test rig and examine the capability of microporous POSS-PCU material 
on air-flow induced voice 
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2. To characterise and optimise POSS-PCU material to provide the suitable 
environment for in vitro cell culture 
- To evaluate the surface properties based on non-porous POSS-PCU material under 
different sterilisation technique 
-  To investigate the microenvironment of microporous POSS-PCUs at different 
porosities 
- To study the protein adsorption pattern on microporous POSS-PCUs at different 
porosities using BSA as a model 
3. To evaluate HBECs growth and differentiation on microporous POSS-PCUs 
- To determine optimal protein level that enhances HBECs proliferative ability 
- To compare HBECs growth on microporous POSS-PCUs at different porosities 
- To differentiate HBECs on microporous POSS-PCUs at different porosities under 
ALI condition 
- To evaluate the characteristic of differentiated epithelium including stratification, 
intercellular tight junction, mucin production and ciliation 
4. To evaluate BM-MSCs growth and chondrogenic differentiation on 
microporous POSS-PCUs 
- To compare BM-MSCs growth on microporous POSS-PCUs at different porosities 
- To differentiate BM-MSCs on microporous POSS-PCUs at different porosities under 
chondrogenic differentiation condition 
- To evaluate the characteristic of chondrogenic-like ECM and cell including sGAG 
and collagen 
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Chapter 3 General materials and 
methods 
3.1 Synthesis and fabrication of POSS-PCU scaffold materials 
3.1.1 Synthesis of POSS-PCU (Prep 9 formula) 
The POSS-PCU was prepared and manufacturing controlled by laboratory technician (Mr 
Arnold Darbyshire). The procedures were described previously elsewhere in detail[83]. In 
brief, 76g of polycarbonate polyol (2000 mwt), and 2g of trans-
cyclohexanechloroydrinisobutyl-silsesquioxane (POSS) (Hybrid plastics Inc, Mississippi, 
USA) were placed in a 500 mL reaction flask equipped with mechanical stirrer and nitrogen 
inlet. The mixture was heated to 135°C to dissolve the POSS cage into the polycarbonate 
polyol and then cooled to 70°C. 20g of Flake 4,4’-Methylenebis(phenyl isocyanate), (MDI), 
was added to the polyol blend and then reacted, under nitrogen, at 70°C - 80°C for 2 h to 
form a pre-polymer. Dimethylacetamide (DMAC) was added slowly to the pre-polymer to 
form a solution; the solution was cooled to 40°C. Chain extension of the pre-polymer was 
carried out by an addition of 2g Ethylenediamine (EDA) in Dimethylacetamide (DMAC) to 
form a solution of POSS modified Polycarbonate urea-urethane in DMAC (Prep9). All 
chemicals and reagents, except POSS, were purchased from Sigma-Aldrich (Gillingham, 
UK). 
3.1.2 Casted (non-porous) POSS-PCU sheet 
Non-porous POSS-PCU was fabricated via the solvent evaporation technique using an 18 
cm Ø stainless steel plate stainless steel plate or a 9 cm Ø glass Petri dish. Required amount 
(mass) of Prep9, 18% (w/w) POSS-PCU in DMAC was calculated from desired thickness of 
the sheet to obtain the required mass using the equation below. 
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Required Mass (g) = Area of the mould (cm
2
) X Desired thickness (cm
2
) X 1.15 
(g/cm
3
)X (100/18) 
Where  1.15 (g/cm
3
) is solid POSS-PCU density and 100/18 is the correction factor when 
DMAC is fully evaporated away. 
After that the pre-calculated amount of Prep9 POSS-PCU was poured onto the mould on 
the scale (Mettler-Toledo, Leicester, UK). The mould was transferred to 65
o
 C incubator 
with a balanced stage to equalise the POSS-PCU thickness. POSS-PCU was left overnight to 
let the DMAC fully evaporate and obtain the non-porous POSS-PCU sheet. 
3.1.3  Microporous POSS-PCU sheet 
The microporous scaffolds were fabricated using phase inversion/particulate leaching 
technique with the pre-sieved NaHCO3 size of 25 - 53 µm at the different percentage (0). A 
mixture of POSS-PCU and 70% NaHCO3 had a very high viscosity that couldn’t place in a 
mould or dip-coated, and a modified version M70% was used instead. By adding more 
DMAC while maintaining the concentration of porogen, the porosity was similar to the 70% 
NaHCO3. The compositions were mixed in the ARE-250 planetary centrifugal mixer 
(ThinkyUSA, Inc., California, USA) at 2,000 rpm mixing step and 1,500 rpm defoaming 
step. This mixture was then poured onto the glass mould while tapping around the edges 
with autoclave tape to obtain the thickness of 500 µm (4 layers X 125 µm). A metal rod was 
used to remove excess mixture and remove air bubbles. Finally, the mould was transferred 
into the deionised water to initiate the phase inversion/particulate-leaching to allow the 
solvent exchange and let DMAC and NaHCO3 micro-particles slowly dissolved to form 
microporous sheets. The water was changed regularly up to 5 times over a 2-day period to 
wash away excess solvent and NaHCO3. 
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Table 3.1 Composition of different percentage (w/w) for microporous POSS-PCU shown in 
every 100 g 
Chemicals 30% NaHCO3 50% NaHCO3 70% NaHCO3
* 
Modified 70% 
(M70%NaHCO3) 
18% POSS-PCU in 
DMAC (Prep9) 
68 g 48 g 28 g 24 g 
Tween 20 2 g 2 g 2 g 2 g 
NaHCO3 25-53 µm 30 g 50 g 70 g 60 g 
DMAC - - - 14 g 
POSS-PCU : NaHCO3 1 : 2.45 1 : 5.79 1 : 13.89 1 : 13.89 
* cannot be used in dip-coating 
3.2 Manufacture of microporous POSS-PCU samples for cell 
culture 
The POSS-PCU sheet was manufactured into the different shape such as dumbbell for 
mechanical testing or, into 16mm Ø circular discs for cell culture, and performed using 
pulsed CO2 laser ablation. Briefly, POSS-PCU sheets were placed on a flatbed of the Trotec 
Speedy 100R (Trotec Laser, Guildford, UK). The shape was designed using CorelDRAW® 
Graphics Suite version X7 (Corel Corporation, Ottawa, Canada) to match the laser software. 
The samples were cut was performed using the laser condition at 6% of 30W Power, 0.6 
cm/s speed and 1,000 frequency for non-porous POSS-PCU and 10.00 power unit, 0.50 volt 
and 9,000 pulses for microporous POSS-PCU. 
3.3 Mechanical properties of POSS-PCU materials 
Mechanical testing of the POSS-PCU materials or laryngeal tissues (n = 6 per condition) 
were performed using a uniaxial tension on the Instron 5565 testing system (Instron 
Corporation, High Wycombe, UK). Specimens were cut into a flat dumbbell shape 
(according to 3.2), mounted onto the grips with a 20 mm path length, and thickness of 
specimens measured using a digital electronic micrometer (UKAS Calibration Ltd, 
Middlesex, UK) for four cross-sectional areas across the dumbbell and were used to 
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calculate mean values and standard deviations. The mean values were input into the 
programme before processing of the mechanical testing software ready for testing. The data 
was plotted and analysed using Bluehill software version 2.9 (Instron Corporation, High 
Wycombe, UK). The maximum stress, strain at break and Young’s modulus were obtained. 
3.4 Surface morphology via scanning electron microscopy (SEM) 
Scanning electron microscopy was performed by SEM Unit (Royal Free Hospital, 
London, UK) Basically, POSS-PCU samples were attached to aluminium stubs with double 
sided sticky tape and coated with gold using an SC500 sputter coater (EMScope, Sussex, 
UK) with a gold target before being imaged at high resolution and analysed using a Philips 
(FEI) 501 scanning electron microscope (Philips, Eindhoven, the Netherlands). 
3.5 Sterilisation of POSS-PCU 
3.5.1 Steam sterilisation (autoclave) 
POSS-PCU samples were placed in the glass bottle filled with deionised water. The bottle 
cap was released a little bit and the autoclave indicator tape was attached. The bottle was 
placed in autoclave machine and sterilised at 121
o
 C, 15 psi for 15 minutes. 
3.5.2 Ethanol cleanse 
POSS-PCU samples were submerged in absolute ethanol (Sigma-Aldrich, Gillingham, 
UK) for 5 min. After that, POSS-PCU scaffolds were transferred into 50 mL tubes filled with 
20 mL of 70% ethanol to rinse the surface. The tube was placed onto a roller shaker for 30 
min. Then, the ethanol was removed from the tube washing steps were performed by adding 
20 mL of PBS and placed on the roller for 15 min. The washing steps were then repeated 3 
times. 
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3.6 Quantification of total protein concentration 
The total protein content was quantified using the bicinchoninic acid (BCA) assay (Pierce 
Biotechnology, Illinois, USA). The BCA Protein Assay combines the well-known reduction 
of Cu
2+
 to Cu
1+
 by protein in an alkaline medium with the highly sensitive and selective 
colorimetric detection of the cuprous cation (Cu
1+
) by bicinchoninic acid.  
The first step is the chelation of copper with protein in an alkaline environment to form a 
blue coloured complex. In this reaction, known as the biuret reaction, peptides containing 
three or more amino acid residues form a coloured chelate complex with cupric ions in an 
alkaline environment containing sodium potassium tartrate.   
In the second step of the colour development reaction, BCA Reagent, a highly sensitive 
and selective colorimetric detection reagent reacts with the cuprous cation (Cu
1+
) that was 
formed in step 1. The purple coloured reaction product is formed by the chelation of two 
molecules of BCA Reagent with one cuprous ion. The BCA/Copper Complex is water-
soluble and exhibits a strong linear absorbance at 562 nm with increasing protein 
concentrations. 
In 96-well, 25 µL of standard or unknown samples were mixed with 200 µL of working 
reagent prepared by mixing 50:1, BCA reagent A: BCA reagent B. The plate was incubated 
at 37
o
C for 30 minutes, cooled to room temperature and measured the absorbance at 562 nm. 
The standard curve of protein concentration was generated using standard bovine serum 
albumin (BSA) provided with the kit. 
3.7 Cell culture and maintenance 
3.7.1 Primary human bronchial epithelial cell (HBECs) 
Human bronchial epithelial cells (HBECs) were purchased from ScienCell Research 
Laboratories (California, USA). The cells were isolated from human bronchi and was 
cryopreserved at Passage 0 to be delivered frozen at >5 x 10
5
 cells in 1 ml volume. The cells 
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were tested by the company and were positive for keratin-18, keratin-19, and vimentin, but 
negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HBECs were 
expanded in T75 cm
2
 flasks with bronchial epithelial cell medium (BEpiCM) (Sciencell, 
California, USA). At passage 1-4 was cryopreserved in BEpiCM with 10% (v/v) DMSO 
(Sigma-Aldrich, Gillingham, UK) in liquid nitrogen storage (-196°C) as a stock 
concentration. 
Cryopreservation vial was removed from liquid nitrogen storage, quickly thawed at 37
o
 C 
and the cells were transferred to a pre-warmed BEpiCM supplemented with growth factors 
(instead of foetal bovine serum), and 1% penicillin/streptomycin. The cells were pelleted at 
1,200 rpm and re-suspended in new fresh media before putting in a T-75 cm
2
 flask. The cells 
were placed in the CO2 incubator (Binder GmbH, Tuttlingen, Germany) with the condition 
of 37
o
 C and 5% CO2/Air with humidity. The medium of 15 mL was changed every 2 days to 
complete cell feeding. HBECs were sub-cultured and used between passages 2-9 for all cell 
culture experiments. 
3.7.2 Human bone marrow-derived mesenchymal stem cell (BM-MSCs) 
Human bone marrow-derived mesenchymal stem cells (BM-MSCs) were purchased from 
ScienCell Research Laboratories (California, USA). Cells were isolated from human bone 
marrow, cryopreserved at passage 1 and delivered frozen at >5 x 10
5
 cells in 1 ml volume. 
BM-MSCs were previously characterised by the company using antibodies specific to CD73, 
CD90, CD105 and positive lipid staining after induced differentiation. BM-MSCs were also 
negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. BM-MSCs were 
expanded in T75 cm
2
 flasks with mesenchymal stem cell medium (MSCM) (Sciencell, 
California, USA). Passage 1-4 was cryopreserved in MSCM with 20% fetal bovine serum 
and 10% (v/v) DMSO in liquid nitrogen storage (-196°C) as stock. 
Stocked vial was removed from liquid nitrogen storage, quickly thawed and placed into a 
pre-warmed MSCM supplemented with MSC growth supplement, 10% foetal bovine serum, 
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and 1% penicillin/streptomycin. Cells were spun at 1,200 rpm, re-suspended in new fresh 
media and plated on a T-75 flask. The cells were placed in the CO2 incubator (Binder 
GmbH, Tuttlingen, Germany) with the condition of 37
o
 C and 5% CO2/Air with humidity. 
The medium was changed every 2 days to complete cell feeding. BM-MSCs were sub-
cultured and used between passages 2-9 for all cell culture experiments. 
3.7.3 Cell expansion and seeding on materials 
The cells were allowed to grow up to confluence (80-90%) and were detached by first 
washing with warm 10 mL phosphate buffer saline (PBS). After washing, PBS was 
aspirated, and approximately 3 mL of 0.25% trypsin-EDTA was added and allowed to 
incubate at 37
o
 C for 3 min. Then, 3 mL of trypsin was allowed to neutralise by adding 7 mL 
of medium, and cell suspension which was collected in a 15 ml centrifuge tube and spun at 
1,200 rpm to concentrate the cell population. The supernatant was discarded and the cells 
were re-suspended in 1-2 mL of fresh medium. 50 µL of sample was stained with an equal 
amount of 0.4% Trypan Blue (Sigma-Aldrich, Gillingham, UK) to determine the amount of 
live and dead cell using the improved Neubauer haemocytometer (VWR International, 
Leicestershire, UK), and the trypan blue exclusion assay. The cell suspension was diluted 
with different amounts of media to obtain cell concentrations for each application such as 5 x 
10
5
 cells/flask for further cell expansion, or 5 x 10
4
 cells/scaffold for the in vitro experiment.  
Pre-sterilised 1.6 mm Ø POSS-PCU discs, were placed into each well of a 24-well tissue-
culture polystyrene (TCP) plate. Culture medium (1 mL) was added in to each well to 
incubate the discs in an incubator with 95% humidified air, 5% CO2, and 37
o
 C for 24h 
before the experiment to ensure the medium had infiltrated though out the material, as well 
as, completed the adsorption of proteins. The initial cell number at 5 x 10
4
 cells per 
scaffold/well (determined from the optimal growth phase of HBECs on TCP, Appendix C) 
was plated on to each scaffold and cultured for 14-35 days according to experiment 
conditions at 37
o
 C with 5% CO2 /95% air. The medium (1 or 2 mL) was changed every 2 
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days and cells on TCP were employed as a positive control for comparison with POSS-PCU 
materials  
3.8 Cell-based assay 
3.8.1 Assessment of cell viability on POSS-PCU 
Alamar Blue™ (AbD Serotec, Oxford, UK) was used to measure metabolic activity of 
cells on TCP and POSS-PCU scaffolds at each time point. Upon entering cells, the blue dye 
composed of resazurin is oxidised to a red coloured dye resorufin, which could be 
quantitatively detected using a fluorescent reader. Viable cells continuously convert 
resazurin to resorufin, increasing the overall fluorescence and colour of the media 
surrounding cells. Alamar Blue™ stock solutions were diluted with cell culture medium at 
the concentration of 10% (v/v). At each time point, the scaffolds were washed with 1 mL of 
media, and then, 10% (v/v) Alamar Blue™ in culture media was added to each well with 
minimal light exposure during aspiration. The 24-well plate was wrapped with aluminium 
foil and incubated at 37
o
 C with 5% CO2/95% air for 4 h. After completion of incubation, 
100 µL solutions of each well was transferred into a black 96 well plate (Thermo-Fisher 
Scientific, 
Massachusetts, USA), and the fluorescence was measured with 530 nm excitation and 
620 nm emission using a Fluoroskan Ascent FL (Thermo-Fisher Scientific, Massachusetts, 
USA). 
           % Reduction of Alamar Blue®       =           FTest      –          Fcontrol            X    100 
                        F100% reduction -   Fcontrol 
Where Fcontrol is the fluorescence from Alamar Blue® in media without cells, Ftest is 
fluorescence from samples, and F100% reduction is a complete reduction of Alamar Blue® 
generated by autoclaving Alamar Blue® in media (according to company’s instruction). 
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After measurement, the scaffolds in each 24 well plate were washed once with 1 mL of 
fresh culture media. Finally, another 1 mL of fresh culture medium was added to each well 
and followed the “regular cell culture scheme”. 
3.8.2 Cell proliferation on POSS-PCU 
Cell proliferation was determined by measuring the amount of total DNA in a given 
population. Briefly, the culture medium was removed from samples and washed with PBS. 
Then, 100 µL of deionised water was added into each scaffold. The scaffold was subjected to 
x3 freeze-thaw cycles by placing in -70
o
C and then room temperature for 3 times to lyse the 
cells to release DNA. The fluorescent dye solution was prepared by dilution to 1 µg/mL 
Hoechst 33258 in buffer solution according to the company’s instruction (Sigma-Aldrich, 
Gillingham, UK). After performing 3 freeze-thaw cycles, the whole supernatant (100 µL) 
was transferred to black 96-well plate pre-added with 100 µL of the dye solution. The 
solution in each well was mixed using a pipette and the plate was then subjected to 
fluorescent readings at 380 nm excitation and 420 nm emission using Fluoroskan Ascent FL 
(Thermo Fischer Scientific, Massachusetts, USA). A DNA standard curve was generated 
using standard calf thymus DNA provided with the kit. The mean fluorescence reading of 
each sample was then compared to the blank. If there was no significant difference (P > 
0.05), the sample was interpreted as DNA not detected. However, if there was significant (P 
< 0.05), the fluorescence was then quantified referring to DNA standard curve and was 
presented in the graph. 
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Chapter 4 Design and 
development of a 3D POSS-PCU 
scaffold for laryngeal implants 
4.1 Introduction  
Loss of laryngeal function severely affects the quality of life of those effected breathing, 
speaking, swallowing, and other basic functions, are all compromised. Conventional voice 
restoration as well as breathing after laryngectomy requires constant maintenance and 
delivers suboptimal phonation at best[84]. Where the laryngeal structures remain in place, 
but remain damaged through scarring leads to distortion of the vocal fold edge, as well as, 
the alteration of lamina propria, viscosity and stiffness[85] of the tissue leading to vocal 
impairment[86]. Speech restoration also is a vital part for functional rehabilitation of patients 
undergoing partial or total laryngectomy[87]. Voice rehabilitation in the latter patients is 
usually accomplished by employing esophageal speech, an artificial larynx, or most recently 
the construction of a tracheoesophageal fistula and use of valve voice prostheses[88]. 
 The field of laryngeal tissue engineering aims to reconstitute structurally and 
restoring the function of the organ using regenerative medicine approaches[89]. To date, 
laryngeal implants have developed in divergent designs for different applications. Most 
implants are primarily used for glottic insufficiencies[90]. These implants have a variety of 
forms including injectable implants consisting of micro-particles for vocal fold 
augmentation[91] and solid implants from titanium[92] and silastic[93] for more permanent 
vocal fold medialisation in patients with vocal cord paralysis. Silicone stents (e.g. 
Montgomery T-tubes, Eliachar stents) are applied to prevent or by-pass life-threatening 
laryngeal stenosis[94], whilst most recently a titanium-based artificial larynx implant is 
being developed to replace oral breathing and speech for laryngectomees[2]. 
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Synthetic materials have many advantageous properties over natural materials; for 
example, the manufacturing and developmental procedure can be easily controlled, and the 
materials can be sterilised in various ways prior to clinical use such as steam sterilisation 
(autoclave), gamma irradiation and ethylene oxide (EtO) gas exposure. Polyhedral 
oligomeric silsesquioxane – poly (carbonate urea) urethane (POSS-PCU) has been shown to 
possess ideal characteristics for 3D scaffolds, such as anti-thrombogenicity[95],  degradation 
resistance[65], and extensive biocompatibility testing over a 3 year period in vivo[69]. In 
terms of sterilisation, it also showed resistance to autoclaving with no cytotoxicity side 
effect[96], which is a very promising property to use for sterilisation of medical device 
according to ISO standards in clinical usage. 
In this study, two different fabrication methods were examined using nanocomposite 
POSS-PCU materials to optimise 1) the 3D structure of laryngeal implants using a 
combination of solvent casting and particulate-leaching/phase inversion coagulation 
techniques and 2) voice simulation of particulate-leaching/phase inversion coagulation 
POSS-PCU material. 
4.2 Materials and methods 
4.2.1 Synthesis of POSS-PCU nanocomposite materials 
The production of polymer has been prepared by Mr Arnold Darbyshire and the process 
was described previously elsewhere in detail[65]. In brief, polycarbonate polyol, and trans-
cyclohexanechloroydrinisobutyl-silsesquioxane were placed in a reaction flask equipped 
with mechanical stirrer and nitrogen inlet. The mixture was heated to 135°C to dissolve the 
POSS cage into the polyol and then cooled to 70°C. Flake 4,4’-Methylenebis(phenyl 
isocyanate), (MDI), was added to the polyol blend and then reacted, under nitrogen, at 70°C 
- 80°C for 2 h to form a pre-polymer. Dimethylacetamide (DMAC) was added slowly to the 
pre-polymer to form a solution; the solution was cooled to 40°C. Chain extension of the pre-
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polymer was carried out by addition of Ethylenediamine in Dimethylacetamide to form a 
solution of POSS modified Polycarbonate urea-urethane in DMAC. All chemicals and 
reagents were purchased from Sigma-Aldrich (Gillingham, UK). 
4.2.2 Fabrication of 3D laryngeal implant structures 
The laryngeal framework was fabricated using a multiple step approach. Non-porous 
POSS-PCU was fabricated using solvent-evaporation techniques at temperature of 65
o
C 
overnight (18h) in metal mould to obtain the desirable thickness (5 mm). The non-porous 
POSS-PCU sheets was cut according to porcine cartilage shape in 2D, and was reshaped to 
form a 3D tubular structure by heating at 140
o
C for 1h. Non-porous larynx structures 
including larynx, and the upper part of trachea were cross-linked using DMAC, and formed 
the 3D larynx and upper airway scaffold. The whole structure was dip-coated in a mixture of 
porogen (25 – 53 µm NaHCO3) and POSS-PCU mixture (50 mL). Particulate-
leaching/coagulation was performed in sterile water to let solvent and NaHCO3 
microparticles slowly dissolved and formed an outer microporous layer. 
4.2.3 Surface morphology using scanning electron microscopy (SEM) 
The fabricated materials were sectioned using scalpel to obtain thin sections containing 
non-porous POSS-PCU in the centre and microporous POSS-PCU coated on both sides. The 
porous section was analysed to examine the surface morphology. The samples sent to SEM 
unit (Royal Free Hospital, London UK) were attached to aluminium stubs with double sided 
sticky tape and coated with gold using (SC500) sputter coater (EMScope, Sussex, UK) with 
a gold target before being imaged and analysed using a Philips (FEI) 501 scanning electron 
microscope (Philips, Eindhoven, the Netherlands). 
4.2.4 Effect of heat aging on mechanical properties of non-porous POSS-PCU 
Non-porous POSS-PCU with thickness of 500 µm was cut into dumbbell shaped, 
specimens were subjected to processing using the heating at 140
o
C at different time points 
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(1h, 3h and 6h)(n = 6 per condition), and at a room temperature at 25
o
 C (n = 6). All samples 
were then subjected to testing the mechanical properties using the Instron 5565 testing 
system (Instron Corporation, High Wycombe, UK) as previously described in section 3.3. 
4.2.5 Mechanical properties of POSS-PCU vs. native porcine tissue 
Mechanical testing of porous and non-porous POSS-PCU, and laryngeal tissues from a 
porcine model (n = 6 per condition) were performed with a uniaxial tension on the Instron 
5565 testing system (Instron Corporation, High Wycombe, UK). Specimens were cut into a 
flat dumbbell shape with 20 mm path length and the thickness of specimens were measured 
using a digital electronic micrometer (UKAS Calibration Ltd, Middlesex, UK) form four 
cross-sectional areas across the dumbbell specimen, and were used to calculate standard 
deviations and mean values. Porcine larynxes were purchased from Orchard Farm (Essex, 
UK). All mechanical properties were measured on the day of organ retrieval. Different areas 
of the organ were sampled to test the supraglottic epithelium, vocal cord, subglottic 
epithelium and thyroid cartilage (Figure 4.1). The mean thickness values of thickness were 
input to the software program before processing of the mechanical tests. Data was plotted 
and analysed using Bluehill software version 2.9 (2010) (Instron Corporation, High 
Wycombe, UK). The maximum stress, strain at break and Young’s modulus were obtained 
for each of the specimens and their respective locations. 
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Figure 4.1 Pictures showing selective tissue region (a), 1 = subglottis, 2 = glottis, 3 = 
supraglottis, and 4 = thyroid catilage, and samples were attached to Instron’s grips for tensile 
testing (b). 
4.2.6 Oscillatory response of coagulated POSS-PCU 
Custom made acrylic tube was designed for the voice test rig (Figure 4.2). Briefly, 
silicone tubing was connected to the air supplier with a reading gauge (L/min). Another end 
of the tube was connected to the Y-shape connector with tubes which led to a pressure metre 
(Comark, Northampton, UK) and a testing chamber with a wetted paper towel to keep 
moisture in the air flow. Microporous POSS-PCU membranes comprised of 50% NaHCO3, 
25-53 µm, were tested with n = 4 per condition at different thickness values (e.g. 0.5 mm, 
1.0 mm, 2.5 mm. 3.0 mm, and 5.0 mm) and were attached to  the square stage on the top of 
the tube. The different levels of strain applied across the membrane was created by marking 
of two positions with a distance of 2.0 cm. Then the membranes were stretched equally to 
2.1 cm and 2.2 cm (5% and 10% strain)(Figure 4.3-a) and no stretch at all for 0% strain. 
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Finally, around the membrane was sealed using sticky tape to prevent the air leakage (Figure 
4.3-b). 
 
Figure 4.2 Schematic diagram presenting the voice test rig. 
 
Figure 4.3 a) strain applied on to POSS-PCU membranes to achieve 10% at 2.2 cm and b) 
sticky tape was sealed around the membrane and microphone was placed at the side to record 
the sound (2 cm, same position in all samples). The arrow show where the “vocal” slit 
vibrated and generated the sound. 
When the air flow gauge was open, a vibration at response was recorded in the 
parameters of the air flow rate, differential pressure, and sound. The air flow rate for this 
experiment was fixed at 5, 10, and 15 L/min plus an initial response if lower or higher than 
2 cm 
2.5 cm 
“Vocal” slit 
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5L/min. The sound from each sample was recorded for 10 seconds at the same position (2 
cm away from the sound source) using an iPhone and microphone (Apple, California, USA). 
The files (.wav) were analysed for average fundamental frequency (F0) and average sound 
energy using Analysis of Dysphonia in Speech and Voice programming software 
(ADSV™)(KayPENTAX, New Jersey, USA). 
4.2.7 Statistics 
The data are compared using a two-way ANOVA with Bonferroni’s multiple 
comparisons test in mechanical testing experiment. Linear regression was analysed using a 
differential pressure, sound energy, and F0. Non-parametric correlation was used to analyse 
the sound energy. All statistical analyses were performed on the data sets using GraphPad 
Prism version 5.01. (2007) P – values < 0.05 were considered to be statistical significance.   
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4.3 Results 
4.3.1 3D laryngeal implant structure 
The fabricated laryngeal framework replica is shown in Figure 4.4. After casted POSS-
PCU sheet was cut into thyroid shape in 2D (Figure 4.4, 1), it was heat aged at 140
o 
C to 
form a 3D tubular structure similar to the native cartilage (Figure 4.4, 2). Non-porous larynx 
structures including the larynx and the upper part of trachea were cross-linked using DMAC 
solvent and formed the 3D larynx scaffold (Figure 4.4, 3). The whole structure was dip-
coated in sodium bicarbonate (NaHCO3) and POSS-PCU mixture, and particle-
leaching/coagulation was performed in sterile water to let solvents and NaHCO3 micro-
particles slowly dissolve to form an outer microporous layer. The fabrication technique 
revealed the full tubular structure was composed of non-porous rigid structures inside and 
soft microporous structure fully covering the outer layer (Figure 4.4, 4). 
 
Figure 4.4 Development of 3D scaffold is demonstrated on the schematic diagram. Step 1, 
casted POSS-PCU was cut in to thyroid cartilage shape (1). The casted thyroid structure was 
heated to 140
o
 C to form a tubular structure (2). Step 2, the thyroid structure was glued 
together with casted tracheal rings (arrow) using DMAC, forming a complete internal rigid 
structure (3).  The whole structure was dip-coated the outer layer with porous coagulated 
POSS-PCU (4), revealed the complete tube with porous structure covered the entire surface. 
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The hemilarynx was fabricated using a similar technique to create a semi-tubular 
structure (Figure 4.5, A) showing the difference of inner lumen (IL) without or with the 
vocal fold structures (VF) which was similar to the native porcine thyroid cartilage (Figure 
4.5, B). A cross-section sample was examined under SEM to identify the microstructures of 
the scaffold. The scaffold presented a complete outer layer of porous structures with an 
internal rigid structure (Figure 4.5, C). The outer layer of coagulated POSS-PCU scaffolds 
with 25 - 53 µm NaHCO3 presented microporous structures with an open network 
throughout the surface (Figure 4.5, D).  
 
 
Figure 4.5 POSS-PCU thyroid shape (A) demonstrates a similar structure to the native 
porcine cartilage (B). High magnification of the cross-section revealed a uniform porous 
structure with rigid casted POSS-PCU in the middle (C), bar = 1 mm. The outer layer also 
demonstrates pores across the surface (D), bar = 30 µm. 
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4.3.2 Effect of heat aging on mechanical properties of casted POSS-PCU 
Mechanical testing showed that there was no significant difference in terms of maximum 
stress and Young’s modulus among the casted samples, which were incubated at 140o C for 
1, 3 and 6 h, respectively, when compared with controls (Figure 4.6). 
  
 
Figure 4.6 The mechanical properties of casted POSS-PCU when exposed to heating at 
different time (n=6). 
4.3.3 Mechanical properties of POSS-PCU scaffold vs. native porcine model 
Different parts of laryngeal tissue and nanocomposite scaffolds were investigated in 
terms of tensile properties as shown in Figure 4.7. In terms of maximum stress, casted 
POSS-PCU (rigid structure) exhibited the highest value at 58.56 ± 3.26 MPa, which was 11 
times higher than that of thyroid cartilage at 5.09 ± 0.90 MPa. Whereas epithelial tissues 
from the supra glottis, vocal cord and subglottis were at 1.32 ± 0.44, 1.97 ± 0.65 and 0.90 ± 
0.46 MPa, respectively, which were not statistically different from coagulated POSS-PCU 
(soft microporous structures) at 0.65 ± 0.02 MPa. A combination of 100:400 µm in thickness 
of casted – coagulated POSS-PCU was also observed in this experiment to study the 
properties of the combined material. Casted – coagulated POSS-PCU exhibited a maximum 
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stress value in between the coagulated polymer only, and the casted only at 4.50 ± 1.04 MPa, 
and there was no statistical difference from that of thyroid cartilage. It’s maximum stress was 
a 7 fold increase was observed when compared with coagulated – sample of POSS-PCU.  
The relationship of stress – strain or Young’s modulus of different materials was also 
studied to determine the stiffness of material (Figure 4.7). Thyroid cartilage presented the 
highest stiffness at 29.42 ± 9.08 MPa while casted POSS-PCU’s was at 17.02 ± 0.90 MPa. 
Supraglottic, vocal cord and subglottic tissues were at 4.11 ± 2.10, 6.03 ± 2.29 and 4.46 ± 
1.60 MPa, respectively, whereas, coagulated POSS-PCU was at 0.40 ± 0.09 MPa. A 
combination of casted + coagulated POSS – PCU again exhibited the higher young’s 
modulus at 2.88 ± 0.33 MPa compared to that of coagulated POSS – PCU. 
 
 
Figure 4.7 The mechanical properties of casted POSS-PCU, microporous POSS-PCU, and 
porcine laryngeal tissues, *** P < 0.001. (n=6) 
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4.3.4 Oscillatory vibration of coagulated POSS-PCU 
 The vibration and response was examined using 50% NaHCO3, (sized 25-53 µm), 
coagulated POSS-PCU (Table 4.1). The response was initiated by the membrane, which was 
elevated to be a dome shape (Figure 4.8), which started to vibrate, and generate sound in the 
thickness range between 0.5 mm to 2.5 mm, however; there were no vibrations at 0% strain. 
In 0.5 mm thickness, only 10% strain of the material was vibrating at air flow rate 7L, 10L 
and 15L per minute. For 1.0 mm coagulated POSS-PCU, the material vibrated at 3L, 5L, 
10L and 15L per minute at 5% strain, however; the material only vibrated at 7L, 10L and 
15L per minute at 10% strain. In 2.5 mm coagulated POSS-PCU, the material vibrated at 3L, 
5L, 10L and 15L per minute at 5% strain whereas only vibrated at 7L, 10L and 15L per 
minute at 10%. Finally, 3.0 mm and 5.0 mm coagulated POSS-PCU had no response at all 
conditions. 
 
 
Figure 4.8 Capture images of the side view (2 cm away from the slit) of microporous 
membrane in resting state (a) and vibrating state while generating sound (b). White arrow 
shows the opened slit (2 cm in length). 
 
  
  
Slit 
Slit 
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Table 4.1 Overview of the vibrational response of coagulated POSS-PCU nanocomposites. (n=4) 
Thickness 0% strain 5% strain 10% strain 
Threshold 5L/min 10 
L/min 
15 
L/min 
Threshold 5L/min 10L/min 15L/ 
min 
Thershold 5L/min 10L/min 15L/min 
0.5 mm 
 
No No No No No No No No 7L/min No Yes Yes 
1.0 mm 
 
No No No No 3L/min Yes Yes Yes 5L/min  Yes Yes Yes 
2.5 mm 
 
No No No No 3L/min Yes Yes Yes 7L/min No Yes Yes 
3.0 mm 
 
No No No No No No No No No No No No 
5.0 mm 
 
No No No No No No No No No No No No 
 
  
63 
 
The differential pressure was measured and plotted against the air-flow rate to see the 
relationship (Figure 4.9). The mean value of the lowest and highest differential pressure 
detected at 1.50 cmH2O and 4.25 cmH2O, respectively. Linear regression of all of the 
conditions revealed slopes that deviated from zero (P < 0.01) and suggested that they had or 
almost linear relationship. However, correlation analysis showed a significance (α = 0.05) 
only in 1.0 mm thick samples, 5% strain (P = 0.0023) and 2.5 mm, 5% strain (P = 0.0298) 
with R
2
 = 0.9954 and 0.9978, respectively. Other samples showed no significant correlation 
(P > 0.05). 
 
Figure 4.9 Mean value of differential pressure increased in higher air-flow rate but showed 
significant correlations only in 1 mm and 2.5 mm with 5% strain (*). (n=4) 
The mean value of sound energy increased when the flow rate was higher at X axis with 
minimum at 69.53 dB and maximum at 84.77 dB (Figure 4.10). Although the trends were 
likely to be non-linear, linear regression test also showed significant deviation from zero in 
all samples (P < 0.05) except for 2.5 mm, 10% strain, which was non-significant (P = 
0.0572). This suggested most of the lines could probably fit in linear correlation as well. 
However, when the correlations were analysed, none was significant (P > 0.05). With the 
combination results, the relationship between sound energy and air-flow rate would probably 
fit more with a non-linear type with a plateau. 
64 
 
 
Figure 4.10 Graph exhibited the increase of sound energy when the air-flow rate was higher 
and in a non-linear pattern. (n=4) 
Fundamental frequency (F0) demonstrated almost a straight line fit (Figure 4.11) when the 
air flow rate increased with no linear regression in all conditions (P > 0.05). Mean 
comparisons of each thickness at 5% and 10% strain were made using a t-test. The results 
presented the significant difference between 1 mm, 5% strain vs. 1mm, 10% strain (mean F0 
= 168.7 Hz and 185.0 Hz) and 2.5 mm, 5% strain vs. 2.5 mm 10% strain (mean F0 = 161.3 
Hz and 188.3 Hz). 0.5 mm, 10 % strain did not have pairs, however; its mean F0 (184.7 Hz) 
is similar to 1 mm, 10% strain and 2.5 mm, 10% strain  (P < 0.05). The higher F0 in higher 
% strain were also noticed in this experiment. 
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Figure 4.11 F0 remained the same when air flow rate was higher, however; F0 significantly 
increased when % strain was higher. (n=4) 
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4.4 Discussion 
The classic paradigm of tissue engineering is three-pronged based on (a) cells acting as a 
guide for native tissue regeneration, (b) biomaterial scaffolds (either synthetic or biologic, 
and (c) regulatory factors, both biochemical and physical, that mediate cellular and  material 
behaviour[97–99]. Our laboratory has demonstrated the advantage of nanocomposite POSS–
PCU for tissue engineering applications in terms of controllable mechanical strength and 
elasticity, high compatibility and resistance to degradation and calcification[95]. Here we 
examined its specific suitability as the basis for a laryngeal scaffold for clinical use. 
The solvent-casting technique provided the rigid non-porous structure, which might be 
suitable for supporting the whole organ structure, as well as, withstanding the environment 
and pressure inside the body. Our data showed that casted POSS-PCU exhibited flexibility 
by shaping this material from 2D to 3D tubular structure under 140°C without changes in 
tensile properties, and the durability with the higher overall maximum stress compared to the 
native thyroid cartilage. The particle-leaching and coagulation technique, in contrast, was 
suitable for creating the soft microporous structures underlying the epithelium with 
interconnected networks suitable for cell growth, which will be discussed in the following 
chapter. Moreover, its tensile properties were similar to those of porcine laryngeal epithelia. 
In addition, a ratio of 100:400 µm thickness of combined casted and coagulated POSS-PCU 
presented improved tensile properties, and revealed the possibility of adjusting the desirable 
tensile and mechanical properties for specific application. 
Debry et al. recently reported a first-in-man total artificial larynx replacement[2]. The 
implant was made of titanium with a porous titanium rings underneath to permit better 
integration of tissue from the proximal trachea and a silicone stent to reduce or by pass 
stenosis. Valves on top of the device are intended to not only help patients swallow better, 
but also restore speech described as an “understandable whispering voice”, though probably 
rather sub-optimal compared to normal speech. Similarly, POSS-PCU has durable properties 
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and a porous component, which facilitates cell and tissue integration. Microporous POSS-
PCU was separately examined for the oscillatory response for voice restoration applications. 
Because of its similar mechanical properties to laryngeal epithelia in porcine vocal cords, we 
hypothesised that microporous POSS-PCU would also respond to the oscillation.  
We set up the voice testing rig using an in-house design acrylic tube to deliver the air 
flow while placing the tube upright so that the POSS-PCU membrane would be under the 
influence of air-flow, and gravity in a similar way to human cords. Inside the tube, the wet 
paper towel was wrapped around to provide the moisture during the air flow because the 
dryness of the material could alter the vibration result[100] while the temperature was 
controlled at ambient (25° C). However, the using of humidity and temperature controller is 
recommended for future work to monitor environment and the previously published 
condition was 25–30° C, at 95% relative humidity[101–103]. 
The thickness of microporous POSS-PCU altered the response to air flow: 0.5, 1.0, and 
2.5 mm thickness generated oscillatory vibration while 3.0 and 5.0 mm did not. When strain 
was increased from 5% to 10%, the air-flow threshold increased from 3L/min to 5 L/min in 1 
mm thickness material and 3L/min to 7L/min in 2.5 mm thickness material, possibly due to 
changing the viscoelastic properties of the material. In tensile testing, Young’s modulus and 
elastic modulus of micro porous POSS-PCU reduced when higher strain was applied. This 
might result in “stiffer” material, which would probably require more pressure to initiate 
vibration and phonation. 
Phonation threshold, pressure drop, or “differential pressure” (our favoured term here) is 
the difference between the pressure of lower glottis and upper glottis and is important to 
initiate vocal fold vibration in man. This experiment measures the pressure difference of 
inside and outside the tube to mimic that phenomenon. Titze et al. showed that vibration 
would require about 2-5 cmH2O pressure drop to generate human voice[104]. Microporous 
68 
 
POSS-PCU material exhibited the differential pressure to be well within this range, also 
demonstrating linear increase with increased air-flow rate.  
The membrane thickness that responded to vibration was thinner than that of normal 
human vocal folds (3-5 mm[75]). However, the quality of “voice” produced was 
quantitatively similar to that in man. In terms of energy, normal speech in daily life of 60 dB 
average with fundamental frequencies around 108 – 129 Hz in male and 183 – 226 Hz in 
female[105]. Microporous POSS-PCU exhibited the F0 161.3 Hz to 188.3 Hz, which is 
between the human male and female range. At threshold pressures, the sound energy 
produced by microporous POSS-PCU was 69.53 dB which is quite close to that of normal 
speech. Furthermore, it also produced higher energy when more pressure or air-flow was 
applied. This suggested that the loudness of sound can be controlled from this material in the 
same physiological way that speech or shouting are achieved in humans. Interestingly, 
POSS-PCU material in the same thickness range but different level of strain could change to 
the higher shifting of F0 or “pitch” after applying more strain. This is similar to the process 
of pitch changing in a human voice by different stretching of the vocal cords. 
4.5 Conclusion 
POSS-PCU material has the potential to form the basis of a 3D laryngeal implant. 
Mechanical properties and oscillatory response indicated how the material could be 
optimised to develop a “voice restoration” prosthesis responsive to human lung-generated 
air-flow. Particle leaching and coagulated POSS-PCU exhibited interconnected microporous 
networks which could be useful for cell integration and coverage. In-depth characterisation 
and cyto-compatibility testing are presented in subsequent chapters. 
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Chapter 5 Pre-optimisation of 
POSS-PCU properties for in vitro 
cell culture                    
5.1 Introduction 
Polyurethane (PU) block co-polymers are the most common class of polymeric 
biomaterials, and are widely used in a broad application range of blood-contacting device 
due to their diversity, excellent mechanical properties and haem compatibility, compared to 
other polymeric biomaterials e.g. PTFE[106]. These block co-polymers are typically 
constructed from a ‘soft’ segment, a polyether, polyester, or a polycarbonate, and a hard 
segment, which contains urethane and/or urea linkages[107].  
Copolymer materials like PUs are different from other non-polymer solid materials, due 
to its unique “microphase separation”. Microphase separation often resulted in hard segment 
(domain) aggregates together with H-bond and therefore, separate from soft segment and 
could be seen in nanoscale surface using Atomic Force Microscopy (AFM) techniques[108]. 
Moreover, these separated features of PU affected how protein was adsorbed when Xu et al. 
demonstrated BSA-nano gold adsorption on polyurethane urea (PUU) and adsorbed more on 
the soft segment (131±36 proteins/µm
2
) than on the hard segment (61±20 proteins/µm2), due 
to hydrophobic interactions[109]. 
As the soft segment is the most vulnerable component of PU[110], efforts have been 
made to improve resistance by varying the soft segment groups dependant on chemistry. 
Therefore, PUs are affected by some in vivo degradation mechanisms. For example, 
poly(ester)urethanes can undergo hydrolytic degradation and are no longer utilised as long-
term implanted devices[111]. Our polymer employed carbonate groups instead, which have 
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been shown to increase the degradative resistance of PU[111], an effect due to the better 
hydrogen bonding between all of the segments[112]. 
Poly(carbonate-urea) urethane based materials were established by incorporation of 
silsesquioxane nanocages by core heat cross-linking to provide molecular stability and has 
been shown to possess anti-inflammatory and anti-thrombogenic properties[69]. These hard 
and soft segments properties are believed to arise from the presence of separated 
microphases of the hard and soft segments in the copolymers which is a result of 
thermodynamic immiscibility of the polar hard segments, and the nonpolar soft 
segments[113].  
Material surface properties influence the interactions that occur at the tissue-implant 
interface and play a role when proteins adsorb on to the materials, and cells come into 
contact with the surface. When the material is implanted into the body, proteins can rapidly 
adsorb on the material surfaces within a short time. As protein adsorption occurs almost 
immediately well before cells arrive at the surface, the cells “sense and feel” primarily a 
protein layer rather than the actual surface of the biomedical material[114]. In addition, 
many factors can influence protein adsorption such as porosity, surface chemistry, energy,  
wettability, charge, topography, and hydrophobic interaction[115].  
Micro-pore structures and porosity can maintain higher proteins adsorption (fibronectin 
and serum albumin) and has been shown to enhance human bone cell attachment on 
hydroxyapatite ceramics[116]. The higher porosity results in higher surface area than 2D 
non-porous materials; therefore, more chance of proteins to be adsorbed to the surface. 
Wettability can be determined using contact angle (θ) measurements, when a liquid droplet 
contacts the material surface. Wettability evaluation usually includes the measurement of 
contact angle (θ) measured in degrees, which indicates the level of wetting. Small contact 
angles (< 90°) correspond to high wettability (hydrophilic), while large contact angles (> 
90°) correspond to low wettability (hydrophobic)[117]
,
[118]. Due to low surface energy, 
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liquids will not wet material surfaces and the contact angle will be greater than 90°; 
therefore, the liquid molecules are more attracted to other liquid molecules compared to the 
polymer surface. θ measurement is the easy way to determine surface properties of bulk 
material; however, micro and nano scale study on surface of copolymer needs to be studied 
to explain more about this phenomenon. 
A better understanding of such phenomenon may lead to the optimal material properties 
of POSS-PCU that could control protein adsorption, cell adhesion, and integration, which are 
the fundamentals. In this chapter, the material properties were examined in different aspects 
by bulk modification and linked all the data together to explain and optimise the 
microporous POSS-PCU material in order to enhance the in vitro cell culture using HBECs 
as a model. 
5.2 Materials and methods 
5.2.1 Sterilisation and effect on casted POSS-PCU bulk properties 
5.2.1.1 Sterilisation of casted POSS-PCU 
The sterilisation was performed on casted non-porous POSS-PCU using autoclave and 
ethanol cleanse previously described in section 3.5. Casted POSS-PCU sterilised from both 
techniques were assessed the bulk properties such as wettability, surface chemistry, SEM 
analysis, and mechanical properties. 
5.2.1.2 Effect of sterilisation techniques on casted POSS-PCU wettability 
Wettability of the scaffold surface was determined using contact angle (θ) measurement 
using DSA 100 drop shape analyser (Krüss GmbH, Hamburg, Germany). The sessile drop 
technique was used. The needle was using a droplet of 20 µl water as the solvent on to 6 
different regions on the surface, and θ was measured (n = 6 per condition) and analysed by 
DSA program version 1.9.2.1.1 (1997-2008). The measurement was performed on normal 
non-porous POSS-PCU sheet, under sterilisation technique (autoclave and EtOH treated) and 
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under single aqueous solution (absolute ethanol, 70% ethanol, and PBS). The lower of θ 
resulted in higher relationship in hydrophilicity and surface wetting (Figure 5.1). 
 
Figure 5.1 Sessile drop shape relating θ and hydrophilic/hydrophobic relationship. 
5.2.1.3 Effect of sterilisation on casted POSS-PCU surface chemistry 
ATR-FTIR spectroscopy (JASCO FT/IR 4200, Jasco, Tokyo, Japan) was used to analyse 
any alteration in the surface chemical functional groups before and after sterilisation.  
Spectra were produced from an average of 20 scans at 4 cm
-1
 resolution over a range of 
600 cm
-1
 to 4000 cm
-1
 wavenumbers. POSS-PCU showed absorption bands characteristic of 
poly(carbonate urea-urethane) with the main peaks from the soft segment at 1738 cm
-1
 
(carbonate C=O stretching from carbonate) and 1242 cm
-1
 (carbonate C-O-C stretching).  
The urethane/urea groups of the hard segment give rise to bands at 3323 cm
-1
 (N-H 
asymmetric stretching), 1525 cm
-1
(CHN deformation) and 1065 cm
-1
(urethane C-O 
stretching). 
The aromatic rings of the urea/urethane hard segments show absorption bands at 1635 
cm
-1
, 1591cm
-1
 and 1465 cm
-1
 ( p-substituted stretching) and also at 1017 cm-1, 957 cm
-1
 (p-
substituted C-H bending) and 791cm
-1
(p-substituted C-H deformation). 
The Polyhedral Oligomeric Silsesquioxane is characterised by the absorption band at 
1112 cm
-1
 (cage Si-O-Si stretching). 
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Alkyl groups from the carbonate soft segment and also iso-butyl POSS give absorption 
bands at 2938 cm
-1
 ( C-H asymmetric stretching), 2802cm
-1
(C-H symmetric stretching) and 
1403cm
-1
(C-C stretching). 
The resulting spectrum represents the molecular absorption and transmission, creating a 
molecular fingerprint of the sample. Absorptions due to water and atmospheric air were 
subtracted. 
5.2.1.4 Effect of sterilisation on surface topography 
The sterilisation was performed on casted non-porous POSS-PCU using autoclave and 
ethanol cleanse previously described in section 3.5. Each sample was placed on the stub and 
imaged as previously described in section 3.4. 
5.2.1.5 Analysis of ethanol extraction of POSS-PCU materials 
In ethanol cleanse, absolute ethanol firstly came in to contact with POSS-PCU material 
and it was known to dissolve POSS crystal. Therefore, the trace of dissolved POSS particles 
was extracted and analyse (Butterworth Laboratories, Teddington, UK). Briefly, 1g of casted 
POSS-PCU or dried microporous (70% NaHCO3) POSS-PCU was weighed into a vial to 
which 5 mL of absolute ethanol was added. After 5 min, the test item was removed from the 
solvent. A 1000ppm solution of POSS in ethanol was also prepared. Ethanol 
extracts/solutions were then tested for volatile and semi-volatile organic components by Gas 
Chromatography Mass Spectrometry (GC-MS) and trace metals by Inductively Coupled 
Plasma Optical Emission Spectroscopy (ICPOES). 
5.2.1.6 Assessment of casted POSS-PCU mechanical properties 
Mechanical testing of the casted POSS-PCU with autoclave and ethanol sterilisation (n = 
4 per condition) was performed with a uniaxial tension on the Instron 5565 testing system 
(Instron Corporation, High Wycombe, UK) as previously described in section 3.3. 
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5.2.2 Material properties of microporous POSS-PCUs 
5.2.2.1 Assessment of microporous POSS-PCU mechanical properties 
Mechanical testing of the microporous POSS-PCU scaffolds at different % NaHCO3 (n = 
6 per condition) was performed with a uniaxial tension on the Instron 5565 testing system 
(Instron Corporation, High Wycombe, UK) as previously described in section 3.3. 
5.2.2.2 Assessment of microporous POSS-PCUs porosity 
Microporous POSS-PCU sheets were fabricated in to 3-mm thickness as described in 
section 3.1.3. They were cut in to 16 mm circle discs (n = 6 per condition), completely dried 
in the oven for 48 h and measured the dry weight. The porosity of each condition was 
calculated using the following equations previously published by Ahmed et al.[83]: 
    Porosity (%) = (1 – d/dp) x 100 
Where d is the density of the scaffolds and dp is the density of non-porous polymer which 
is equal 1.15 g/cm3. The density of the scaffold, d, can be calculated from: 
     D = m/v 
Where m is the mass and v is the volume of the scaffold. 
5.2.2.3 Assessment of microporous POSS-PCU permeability 
Water permeability of microporous POSS-PCU samples were assessed using custom 
designed apparatus by connected to 500 mL pressure infuser bag to a pressure metre (Figure 
5.2). Briefly, the microporous POSS-PCU sheets were cut into 2 cm x 2 cm, samples with a 
standard thickness value of 500 µm (± 25). The membrane was inserted in to the stage. The 
cover was mounted across the sample and placed in to the holder followed by 4 bolts. Then, 
the bolts were tightened to prevent the side leakage and forced the water to pass through 
membrane. The water pressure was generated by 500 mL pressure infuser set to 100 mmHg 
using the pressure metre. Measurements were recorded over a 1 min interval. The amount of 
dH2O that passed through the membrane was collected using an analytical balance (Mettler-
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Toledo, Leicester, UK). Microporous POSS-PCU sheets composed of 30% NaHCO3, 50% 
NaHCO3, M70% NaHCO3, coagulated POSS-PCU with no NaHCO3, and non-porous casted 
POSS-PCU were used in this experiment. (N = 6 per condition) 
 
Figure 5.2 Schematic representative of a water permeability testing system. 1) stage and 
lid with 1cm X 1cm sample window, 2) sample sheets, 3) pressure metre, and 4) tubing 
connected to 500 mL pressure inducer. 
5.2.2.4 Pores morphology of microporous POSS-PCU using scanning electron 
microscopy (SEM) 
Samples were processed, placed on the stubs and imaged as previously described in 
section 3.4. 
5.2.3 Effect of sterilisation on bovine serum albumin (BSA) adsorption of 
microporous POSS-PCU 
Bovine serum albumin (BSA) was used as an adsorption model in this experiment to 
mimic the protein-material interaction when the plasma comes into contact with the material. 
BSA is the most abundant protein in the plasma[119], have been used in adsorption 
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experiment on many materials including polymer[109,120–122], and is compatible with the 
BCA assay protein quantification kit (Pierce Biotechnology, Illinois, USA).  
Total protein adsorption was quantified using protein depletion in bulk solution method 
adapted from Akkas et al. [123]. 16 mm Ø scaffold discs with thickness of 500±25 µm were 
placed in 7 mL bijou tubes. Then, 1 mL of 100 µg/mL or 500 µg/mL BSA in PBS was added 
into each tube. Incubation of each sample was performed at 37
o
 C for 24 h.  The depletion of 
protein (BSA) in the bulk solution was investigated using the BCA protein quantification kit 
previously described in section 3.5. The absorbance was read at 562 nm. The data were 
normalised to % adsorption using equation below. 
 % Adsorption =   Absorbance total protein – Absorbance sample        X 100 
       Absorbance total protein - Absorbance blank 
Adsorbed protein amount was also calculated referring to BSA standard curve. 
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5.3 Results 
5.3.1 Sterilisation and effects on casted POSS-PCU bulk properties 
5.3.1.1 Effect of sterilisation techniques on casted POSS-PCU wettability 
 Wettability of the materials after sterilisation was determined by θ measurement to 
investigate the effect on surface properties. The θ quantitative measurements and qualitative 
images were presented in Figure 5.3. The θ of non-treated POSS-PCU was 112o ±4.38 
whereas the autoclaved POSS-PCU was significantly lower at 96
o
 ±3.48 (P < 0.05). The  
EtOH cleansed POSS-PCU presented significantly lower θ at 76o ±3.48 (P < 0.05) which had 
no difference from gold-standard tissue-culture TCP’s (74o ±3.32, P > 0.05). 
 
Figure 5.3 θ of casted POSS-PCU materials before and after autoclave and ethanol cleanse, 
comparing to gold standard tissue-culture TCP. (ns = non-significant, *** P ≤ 0.001) (n=6) 
5.3.1.2 Effect of sterilisation on casted POSS-PCU surface chemistry 
Sterilisation techniques had an effect on detection of chemical groups on POSS-PCU 
surface. ATR-FTIR showed significant changes in the peak of C=O (1737.55 cm-1), C-O-C 
(1241.93 cm-1), and Si-O-Si (111.76 cm-1) (Figure 5.5). The absorbance of each peak was 
extracted using Microspectra Analysis software. Statistical analysis (Figure 5.4) revealed 
autoclave samples and EtOH treated samples had significant increase of C=O and C-O-C 
peaks but significant lower in Si-O-Si peak comparing to control POSS-PCU. 
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Figure 5.4 Autoclave samples and absolute EtOH treated samples had highly significant 
difference in these three peaks comparing to control POSS-PCU (**P ≤ 0.01 and ***P ≤ 
0.001).(n=6)
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Figure 5.5 FTIR analysis showed absorbance changes in C=O, C-O-C and Si-O-Si peaks after sterilisation. 
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5.3.1.3 Effect of sterilisation on surface topography 
Qualitative surface topography was visualised using SEM in Figure 5.6. POSS-PCU 
control presented structures similar to the cracks, or aggregation of 5 µm and larger particles 
covering most of the surface. However, autoclave and EtOH treated POSS-PCUs had a 
relatively smoother surface comparing to the control. The large particles disappeared but 
small particles less than 5 µm still presented and distributed slightly on the surface. 
 
Figure 5.6 SEM images on surface of (a) control POSS-PCU, (b) autoclave POSS-
PCU, and (c) EtOH treated POSS-PCU. 
81 
 
5.3.1.4 Analysis of ethanol extraction of POSS-PCU materials 
There was no leachable organic compound detected (from hard or soft segments of 
POSS-PCU) other than ethanol and the internal standard observed in the GCMS analysis. 
ICPOES analysis demonstrated silicon leached from casted POSS-PCU was less than 10 
µg/g sample (detectable in very low amount) while the 70% NaHCO3 POSS-PCU was 
detected at 12 µg/g sample. 
5.3.1.5 Effect of sterilisation on material mechanical properties 
There was no significant difference between all pairs of samples (P > 0.05) in terms of 
maximum stress and Young’s modulus (Figure 5.7), suggested that sterilisation techniques 
did not affect the mechanical properties of the material.  
 
 
Figure 5.7 Showing mechanical properties of POSS-PCU after sterilisation comparing to 
non-treated control. (n=4) 
5.3.2 Material properties of microporous POSS-PCUs 
5.3.2.1 Assessment of microporous POSS-PCU mechanical properties 
In Figure 5.8, the mechanical properties of microporous POSS-PCU materials were 
determined using the maximum stress and Young’s modulus, which significantly decreased 
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in the higher % of NaHCO3 (P ≤ 0.001 in all pairs). The means of stress were 0.98±0.07, 
0.63±0.06, and 0.19±0.02, for 30%, 50%, and M70% NaHCO3 respectively, whereas the 
means of Young’s modulus were 0.26±0.02, 0.19±0.01, and 0.13±0.01, respectively. 
 
Figure 5.8 Mechanical properties of microporous POSS-PCU materials, showing the 
maximum stress at break point of the materials (left), and the stiffness presented in Young’s 
modulus (right). (***P ≤ 0.001) (n=6) 
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5.3.2.2 Assessment of microporous POSS-PCUs porosity 
The average % porosity of microporous POSS-PCUs were 86.69%, 90.75% and 94.37% 
for 30%, 50% and M70% NaHCO3, respectively. This indicated the porosities significantly 
went up (P ≤ 0.001 in all pairs) when increasing the % NaHCO3 (Figure 5.9). 
 
Figure 5.9 Porosities of microporous POSS-PCUs, showing the mean value of 30%, 50% 
and M70% NaHCO3 (*** P ≤ 0.001) (n=6) 
5.3.2.3 Assessment of microporous POSS-PCU permeability 
The determination of permeability was shown in Figure 5.10. The M70% presented the 
significantly highest water flow at 361.0 L/cm
2
/min (P ≤ 0.001). The 50% NaHCO3 
demonstrated the water flow at 28.85 L/cm
2
/min which was significantly higher than the 
30% NaHCO3 at 12.17 L/cm
2
/min (P ≤ 0.05). Despite some permeability presented in the 
30% NaHCO3, it did not have any statistically difference from the non-porous POSS-PCU, 
which was the negative control and exhibited no water permeability (P > 0.05). 
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Figure 5.10 Water permeability of non-porous and microporous POSS-PCU materials. (ns = 
non-significant, * P ≤ 0.05, *** P ≤ 0.001) (n=6) 
5.3.2.4 Pore morphology of microporous POSS-PCU using scanning electron 
microscopy (SEM) 
Qualitative images from random locations of the samples were shown in Figure 5.11. The 
cross-sectional images showed the higher inter-connected pores and the higher open porous 
structure on the surface when increasing the %NaHCO3. 
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Figure 5.11 SEM images of cross-sectioned microporous POSS-PCUs in different % 
NaHCO3
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5.3.2.5 Effect of sterilisation on BSA adsorption of microporous POSS-PCUs 
BCA protein assay demonstrated a linear relationship of spectrophotometric absorbance 
and BSA concentrations shown in Figure 5.12 (P < 0.05, R
2
 = 0.9827). The depletion of total 
protein in the bulk solution was determined by % adsorption. Microporous POSS-PCUs with 
different types of sterilisation were observed the adsorption of BSA at 100 µg/mL and there 
were significant difference in % adsorptions between autoclaved samples and EtOH cleansed 
samples (P < 0.05). For autoclaved samples, there were no significant differences (P > 0.05) 
of % adsorption among 30%, 50% and M70% NaHCO3 (average = 16.65%, 13.20%, 
and17.53%, respectively). However, the ethanol treated samples demonstrated significantly 
higher % adsorption comparing to the autoclaved samples (P < 0.001). The 30%, 50% and 
M70% NaHCO3 presented the average % adsorption at 38.41%, 68.37%, and 93.68%, 
respectively. 
 
Figure 5.12 Graphs showing a linear relationship of absorbance and BSA concentration 
(left), and % adsorption at 100 µg/mL BSA (right). ***P < 0.001, ns = non-significant (n=4) 
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5.4 Discussion 
5.4.1 Sterilisation and effect on casted POSS-PCU bulk properties 
5.4.1.1 Sterilisation techniques had an effect on POSS-PCU wettability 
Surface wettability was also examined for POSS-PCU material under different 
sterilisation techniques. Non-porous POSS-PCU was chosen in the θ experiment to reduce 
the effect of open pores on surface in particle-leaching/coagulation samples, which could 
have a top-up effect and change the θ as a result of topography changing. Our results showed 
the original form of non-porous POSS-PCU was relatively hydrophobic (θ > 90o). However, 
material surface became more hydrophilic after sterilisation, especially the EtOH treated, 
which demonstrated the θ similar to TCP’s. Lower contact angle resulted in higher surface 
energy and wettability, therefore, the solution spreads more on the surface and proteins have 
more chance to interact with the surface. Regardless of the literatures, cells effectively 
adhere onto polymeric material surface with θ of 40-70o [124],[125],[126],[127]. This led to 
our hypothesis that EtOH treated POSS-PCU would probably have better protein 
adsorptions, thus, improving of cell-material interaction in the experiment. 
5.4.1.2 Sterilisation techniques altered the surface chemical groups 
Polyurethane-based materials (PUs) are frequently used in a variety of blood contacting 
medical devices due to their desirable mechanical properties, fatigue resistance, and 
acceptable hemocompatibility[128]
,
[129]. Material surface usually interacts with 
environment; therefore, changes of surface chemicals after sterilisation were also 
investigated using ATR-FTIR. Our material also showed the different characteristic of the 
surface after sterilisation process in aqueous solution. POSS-PCU samples were submerged 
in deionised water during autoclave while ethanol cleanses, samples were submerged in 
absolute ethanol, 70% ethanol, and PBS, respectively. After the process, they were measure 
chemical groups by ATR-FTIR and presented difference absorbance in the peaks of C=O, C-
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O-C and Si-O-Si, comparing to the control. The samples after sterilisation increased in the 
peaks of C=O and C-O-C but reversely decreased in Si-O-Si. This indicated the less 
appearance of POSS but probably more enrichment of PCU segments and suggested there 
were some factors that altered the material surface.  
According to ATR-FTIR profiles we had come up 2 hypotheses which were 1) the 
washing away of unreacted POSS on the surface and 2) the response of material surface due 
to aqueous environment. There were possibilities that the surface alteration was caused by 
either washing of POSS or surface response or a combination of these two. Our preliminary 
experiment on POSS particles indicated that they could be dissolved in absolute ethanol but 
not water (data not shown). In autoclave samples, reduction of POSS peak but presented 
more C=O and C-O-C peaks is probably cause by just the surface response to aqueous 
solution. C=O and C-O-C was presented mostly in the hard segment that was shown the 
schematic diagram of POSS-PCU molecular structure in Figure 1.3. When the hard segment 
of POSS-PCU appeared more on the surface, it probably create more negative dipole on the 
surface caused by C=O and C-O-C. 
PUs are copolymers constructed form a mixture of soft and hard segments that form a 
microphase-separated structure as a result of thermodynamic immiscibility the polar hard 
segment and the relatively non-polar soft segment[113]. Agnihotri et al. had investigated the 
reorientation of PU’s surface using topographical images from atomic force microscopy 
(AFM). The result demonstrated the hydrophilic hard segment of poly(urethane urea) 
appeared more on the surface with rougher structure after incubate the material in aqueous 
solution (1mM phosphate buffer) after 24h and was quite different from those of ambient 
conditions (air) [107]. Likewise, the hydrophilic part of POSS-PCU component might 
rearrange and come up to the surface as well. 
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5.4.1.3 Wettability results were related with chemical group changes  
This result of FTIR related back to the contact angle results. When the hydrophilic part of 
the polymer appeared more on the surface, it could affect in the reduction of θ. There was 
demonstration previously that the θ of autoclave conditions reduced the contact to around 
96
o
 while the ethanol treated reduced it to around 76
o, which was similar to TCP’s at 74o. 
When relating θ profile to the ATR-FTIR profile, the information was relevant to each other 
by the more appearance of C=O and C-O-C when exposed in aqueous solution (water in 
autoclave and ethanol/PBS after ethanol cleanse), and resulted in the more hydrophilicity 
(reduction in θ).  
However, the ethanol treated had higher hydrophilicity than the autoclave one. This might 
be another effect of washing POSS away by absolute ethanol which was mentioned 
previously. The θ measurements of POSS-PCU treated in single type of solutions 
demonstrated that they did not reduce straight away to 76
o
 after treated with absolute ethanol 
but reduce in different degree and PBS demonstrated the most reduction of θ. This also 
confirmed that in ethanol cleanse technique, there might be 2 effects involved which were 1) 
the washing away of unreacted POSS (presented by ATR-FTIR) and 2) surface 
rearrangement under PBS solution (presented by contact angle profile).  
5.4.1.4 Sterilisation techniques affected the surface but not the bulk 
mechanical properties of the material 
The qualitative confirmation of surface changes had demonstrated in SEM images. Non-
treated POSS-PCU had obvious rough structure on the surface which was probably caused 
by unreacted POSS particles aggregated on the surface, while the autoclave and EtOH-
treated had changed to smoother surface. The analysis of ethanol extraction by ICPOES 
showed that silicon was detectable but in very low amount in ethanol extracts solution. This 
had confirmed that POSS leached out and was accounted for surface changing. However, 
GCMS results demonstrated no organic compounds were detected, especially the aromatic 
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compound from the hard segment which is carcinogenic. This also indicated that despite the 
washing away of unreacted POSS on the surface, the ethanol rinse did not break the main 
chemical structure of POSS-PCU. The result was also confirmed by no significant changes 
of mechanical properties of tested on the materials in different sterilisation techniques. 
Notably, the EtOH cleansed POSS-PCU had no significant difference of contact angle 
comparing to TCP which was commercially optimised for cell culture. Therefore, EtOH 
treated POSS-PCU would have the similar protein adsorption and cell viability to TCP. 
5.4.2 Material properties of microporous POSS-PCUs 
Tissue engineering employed scaffolds as a matrix for cell seeding. The architecture of 
3D structures plays critical role in cell adhesion, proliferation, migration and organisation 
into specific tissue while creating extracellular matrix component[130]. There were various 
ways to create the  microporous structures in the polymer scaffold such as gas foaming[131], 
freeze-drying[132], and particulate leaching[133]. The focus was on particulate-leaching 
technique regardless of its simplicity and cost-efficiency[134]. The fabrication of 
microporous POSS-PCU scaffold employing this technique had been reported by Ahmed et 
al. using POSS-PCU with 40 µm NaHCO3 for vascular graft application[83]. Also, this 
fabrication technique had been used in subsequent research such as POSS-PCU scaffold with 
140-150 µm NaCl for auricular reconstruction[135]. NaHCO3 was employed in this study 
because of its advantage in commercially available in various pre-sieved particle sizes 
(TATA chemicals, Northwich, UK). In this study, the commercial pre-sieved NaHCO3 were 
obtained, however; the sieving was proceeded again to obtain the range of 25-53 µm. This 
range was interesting because the cell size (planimetry width) is approximately 10 µm for 
nasal and bronchial epithelial cells[136], therefore, ideal pores should be slightly bigger to 
fill up couple of cells and allow them to have cellular interactions. 
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5.4.2.1 More porogens reduced the bulk mechanical properties 
Different % NaHCO3 was studied to see the effect on material properties. Mechanical 
properties are one of the criteria in biomaterial sciences. It demonstrated that increasing of % 
NaHCO3 resulted in significant reduction in strength (maximum stress) and elasticity 
(Young’s modulus). This point should be aware of when optimising % particles for making 
the actual 3D organ to make the scaffold integrated by new tissue and withstand the 
premature collapse. 3D scaffold offers the essential support for cells to proliferate and 
maintain their growth. The requirements for promoting cell growth into the functional tissue 
require the scaffold to offer several unique features such as porosity, interconnectivity, 
surface wettability, protein adsorption, and cytocompatibility. 
5.4.2.2  More porogens increased the porosity 
High porosity is one of the conditions to provide space for the cells to attach and generate 
extracellular matrix[137]. The porous structure also enables angiogenesis after implantation; 
therefore, blood vessels can develop and supply oxygen and nutrients to the construct. Our 
data showed scaffolds had high porosity around 86% or above and the porosity had 
significant increase when % NaHCO3 was higher. The explanation why all scaffold had 
porosity greater than 80% had been revealed when looking into its mixed compositions. P9 
POSS-PCU (18% w/w POSS-PCU) had already contained 82% w/w of DMAC as a solvent 
while % NaHCO3 was varied such as 30% w/w, 50% w/w or 60% w/w for modified 70%, 
were mixed later to create porous structure. The major of compositions of the whole polymer 
were NaHCO3 and DMAC (solvent) which will be dissolved away during particle-
leaching/coagulation and left a lot of space in the POSS-PCU scaffold as pores. 
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5.4.2.3 More porogens increased opened pores on the surface, inter-
connectivity, and water permeability   
The porosity alone might not represent how well the pores are interconnected and this 
might affect insufficient water permeability. Therefore, the permeability testing was carried 
out using our own custom-made tube. The results showed in our study that incorporating 
NaHCO3 particles promoted open pores to the surface as well as interconnections between 
pores, thus, the water could pass through, while the non-porous did not present water 
permeability. This indication confirmed that incorporating of porogen is necessary if water 
permeability is taken into account. The quantitation of water also related to how well the 
pores connected. M70% had presented the significantly higher water permeability than 30% 
and 50% NaHCO3 and was confirmed by SEM images to have more interconnected pores 
when increasing the % NaHCO3.  These findings were very important for the nutrient 
transportation in the following experiments such as air-liquid interphase culture as well as 
enhancing the cell integration to the scaffold (Chapter 6). 
5.4.2.4 Ethanol sterilisation promotes the protein adsorption of 
microporous POSS-PCU 
When material is implanted in the body, it will interact with protein in seconds and result 
in protein adsorption on the surface. As proteins coats the material surface, the cells “see” 
the material as a layer of proteins and this attracts the cell and promote cell attachment or 
integration[138]. Colorimetric BCA assay was employed to quantified total proteins in bulk 
solution before and after adsorption process on microporous material. The EtOH treated 
samples presented significantly higher adsorption rate comparing to the autoclave samples. 
This might relate back to the θ profile on material surface after sterilisation (96o for 
autoclave and 76
o
 for EtOH treated). Tamada and Ikada had reported the optimal θ that 
promote both maximum protein adsorption and cell adhesion was around 60-80
o
 and 
polysterene material (θ = 75o±2) fell in to this category[139]. This also similar to our own 
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measurement (θ = 74o±3.32) of the TCP which is commercially optimised for cell culture. 
M70% NaHCO3 had significantly more adsorption than the 30% and 50% NaHCO3. This 
might also be the influence of interconnectivity between pores of the material. The more 
interconnectivity of M70% NaHCO3 might lead to the higher inflow and more interaction to 
inner surface. 
Microporous POSS-PCU had shown promising characteristics for cell culture; however, 
more studies need to be carried on in the future to get better understanding of this material’s 
behaviour. Sterilisation techniques affected the surface properties of the scaffolds with 
changes in protein adsorption rate. The wettability of the bulk surface and chemical groups 
were examined. According to protein adsorption principles, many theories could be applied 
but the one has not been examined is the electrostatic interaction via surface charge. 
Sanchez-Perez et al. investigated BSA adsorption to hydrophobic polystyrene nanosphere 
and found it adsorbed more when the more negative charge was presented[140].  In addition, 
Khorasani et al. had presented O2 plasma treated increased more negative charges on silicone 
and PU surface as well as enhanced fibroblasts attachment and growth[141]. However, too 
much force of electrostatic or hydrophobic interaction can have a negative effect and change 
the orientation or conformation of proteins and therefore, loosing of their function[142]. 
Our result showed the θ of EtOH treated POSS-PCU reduced to the similar level to the 
TCP and resulted in significant protein adsorption. This phenomenon cannot be clearly 
explained at this moment but will be the challenging study in the future regarding surface 
charge. Zeta potential measurement could be another interesting method to study the 
negative or positive charge on POSS-PCU surface related to electrostatic protein adsorption 
and cell attachment. 
5.5 Conclusions 
Incorporation of micro-particles such as NaHCO3 enhances the benefit of open pores on 
surface as well as interconnected pores related to the water permeability. However, 
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increasing of porosity (% particles) might lead to the lower mechanical properties which 
might have to be aware of. In addition, the sterilisation techniques did affect the changes on 
surface properties of POSS-PCU; however, they did not affect the bulk mechanical 
properties or induce the destruction that may cause the harmful chemicals. The protein 
adsorption results show significant difference, due to the changes in surface properties. 
Ethanol sterilisation induced more protein adsorption of the materials than those in 
autoclave. This technique was chosen for the cell culture seems to be the optimal option for 
disinfecting the material for in vitro culture with more favourable cell growth. The full study 
on HBECs growth and differentiation will be fully presented in the following chapter. 
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Chapter 6 Human bronchial 
epithelial cell culture and in vitro 
epithelialisation on microporous 
POSS-PCU scaffold 
6.1 Introduction 
The airway system can be divided into two discrete functions, 1) the conditioning part in 
which the inhaled air is cleaned, moistened, and transported to the distal part of the airways, 
and 2) the respiratory part where the blood is oxygenated, the alveoli. The conditioning part 
comprises of the nasal cavities, pharynx, larynx, trachea, bronchi, and large and terminal 
bronchioles, and the respiratory part of respiratory bronchioles and alveolar ducts[143]. The 
main cell types of the airway epithelium are ciliated, goblet, and basal cells[79]. Goblet cells 
secrete mucus to the airway lumen which lubricates the apical surface of the epithelial layer, 
moistens the inhaled air and helps to trap pathogens and foreign material particles from the 
environment[80]. 
 The need for a prosthetic upper airway replacement is continually modified by improved 
surgical techniques with primary reconstruction and interventional techniques. Synthetic 
prostheses such as flaps, tube constructs, and stents have been employed to maintain the 
structure of upper airway for the patients who have received laryngotracheal reconstructions 
due to disease, congenital defects or trauma. Previously, the synthetic prosthesis were 
usually made of rigid materials such as stainless steel[144]
,
[145], silicone elastomers 
(silastic) [146]
,
[147]
,
[148], and silicone with a Dacron (PET) cover[149]. However, these 
materials did not become well integrated into the surrounding tissues. They also had 
problems with repeated infections, exhibited poor integration and subsequent dislodgement, 
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and developed granulation tissue at the anastomosis leading to airway 
obstruction[150]
,
[151]. Modern implant designs have been developed and are now more 
sophisticated, with microstructures to allow more integration to the native tissues. Recently, 
microbead-based titanium implants have been developed for otorhinolaryngologeal 
applications[152]. The openly porous structures between the microbeads allow for better 
integration of the host tissue in vivo[152]
,
[153]
,
[60] which is a very important characteristic 
to sustainably keep the implant in place. This material has been subsequently studied in 
surgical sheep model[154] and used in a clinical trial for total laryngectomised patients to 
study tissue integration of an artificial larynx structure[2]. 
Creating a new functional laryngotracheal tissue is the ultimate goal for patients who 
have endured repeated surgeries. The optimal tissue repair for laryngotracheal 
reconstructions combining all 3 basic components, which are 1) structural support, 2) a 
functional mucosal lining and 3) vascular supply, has not been achieved yet despite many 
clinical advances in this area[155]. The nanocomposite material POSS-PCU has proven to be 
a good material for production of 3D hollow tubular organs, including 25mm diameter 
bypass grafts, about to enter clinical trials[95] and an airway replacement (trachea) in a 
compassionate case study[30]
,
[156]. Also, it demonstrated that the combination of 2 
fabrication techniques can successfully create a tubular structure for laryngotracheal 
applications, with a supporting rigid structure inside and microporous structure outside in 
chapter 4. This material has great potential to be further developed as a laryngeal implant for 
clinical applications. In this study, the microporous POSS-PCU material was optimised for 
in vitro epithelialisation of human bronchial epithelial cells (HBECs). In addition, the study 
of cell interactions with the scaffold material and examination of the gross morphology, will 
assist with future research in using either an acellular version of this microporous scaffold 
which can for example, act as a stent, or advance the tissue engineering approach to 
laryngeal reconstruction through the use of a cell-seeded scaffold to treat dysfunction. 
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6.2 Materials and methods 
6.2.1 Culture media adsorption and HBECs growth on microporous POSS-
PCUs 
6.2.1.1 Optimisation of pre-adsorption time of cell culture media 
The effect of protein adsorption was further investigated with a microporous material 
samples, which were pre-adsorbed with 1 mL of serum free cell culture media supplemented 
with artificial growth factors at different time points of 6h, 12h, 24h, and 48h. The reduction 
of proteins in the bulk solution was evaluated using a BCA assay protein quantification kit 
described in section 3.6. The optimal pre-adsorption time was determined where there was 
no more reduction of proteins in the bulk solution. 
6.2.1.2 HBEC’s growth on microporous POSS-PCUs 
The seeding and culture of HBECs were performed according to section 3.8 using 
BEpiCM culture medium. Cell viability (n = 6) was assessed at day 1, day 4, day 7, day 11, 
and day 14 according to section 3.9. Cell proliferation was evaluated using total DNA (n = 4 
per condition) was evaluated using the same time period as described in section 3.10. The 
scaffolds from day 7 were fixed and stained with phalloidin, anti-human vimentin, and anti-
human ki-67 according to section 6.2.3. The total counts per field of view (560 x 420 µm) 
was not less than 6 frames and 250 cells per condition were recorded and analysed using 
ImageJ version 1.47 (National Institutes of Health, Maryland, USA). 
6.2.2 Differentiation of HBECs via air-liquid interface cultures 
6.2.2.1 HBEC culture and maintenance 
HBECs in a T75cm
2
 flasks were cultured to confluence the washed with 10ml of 20mM  
PBS without Ca
2+
 and Mg
2+
 . Next, 3 mL of 0.025% trypsin was added. The flask was 
incubated in 37
o
 C for 3 minutes until the cells became easily detached with gentle tapping 
of the side of the flask. 7 mL of fresh BEpiCM media (ScienCell, California, USA) was 
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added and the cell suspension was transferred into a 15 mL tube. The tube was centrifuged at 
1,200 rpm for 5 minutes, after which the supernatant was discarded and the cell pellet was 
resuspend in 2 mL of new fresh BEpiCM media. A viable cell count was performed using 
the Trypan Blue exclusion assay followed by counting using a haemocytometer. 
6.2.2.2 Seeding cell on polyethylene terephthalate (PET) transwell inserts 
In a 24-well plate, 500 µL of BEpiCM was added to each well. A Falcon® 1.0 µm pore 
size polyethylene terephthalate (PET) (Becton Dickinson Labware, Claix, France) filter 
membrane was used as a positive control and was placed into the wells. Then, the upper 
chamber was filled with 200 µL of BEpiCM. 3 x 10
4
 cells (1 X 10
5
 cells per cm
2
) were 
plated on to PET insert to promote cell proliferation and growth until nearly- confluent, 
according to the manufacturer’s instructions. The PET inserts with adhered cells were 
cultured under Pneumacult™-ALI conditions as shown in Figure 6.1 for 3 days to promote 
cells attachment. After day 3, all the scaffolds were “air-lifted” by replacing 500 µL of 
Pneumacult™-ALI (STEMCELL technologies, Cambridge, UK) to the basal chamber only 
while the upper chamber was left empty to allow the cells to be exposed to the air. Nutrient 
levels were maintained by replacing the media in the lower chamber with fresh medium 
every 2 days. 
6.2.2.3 Seeding cell on POSS-PCU transwell inserts 
POSS-PCU scaffolds at different % NaHCO3 were cut in to 16 mm Ø discs and clipped to 
CellCrown™ polycarbonate transwell housing for 24-well plate (Scaffdex Oy,Tampere, 
Finland).  In new 24-well plate, 1.2 mL of BEpiCM was added into each well. POSS-PCU 
inserts were placed into the well and upper chamber was filled with 500 µL of 
Pneumacult™-ALI. 8 x 104 cells (1 X 105 cells per cm2) were plated on to POSS-PCU 
inserts. POSS-PCU scaffolds with cells were cultured under BEpiCM for 3 days to promote 
cells attachment. After day 3, all the scaffolds were “air-lifted” by replacing 1.2 mL of 
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Pneumacult™-ALI to the basal chamber only while upper chamber was empty to let cells 
exposed to the air. Finally, the lower chamber was replaced with new medium every 2 days 
(Figure 6.1). 
 
Figure 6.1 Illustration of a) POSS-PCU material clipped in housing inserts, b) the insert was 
put in transwell, and c) schematics of changing submerged culture (air-lifting) to air-liquid 
interface cultures (PneumacultTM –ALI) after 3 days. 
6.2.2.4 Assessment of cell proliferation 
Due to the limitation of cell viability assay that cells need to be submerged in culture 
media, only the total DNA quantification assay was employed as a measure cell 
proliferation. The procedure was performed as described in section 3.10. 
6.2.3 Characterisation of HBECs and differentiated HBECs 
HBECs were characterised via immunofluorescent staining using fluorescence dye and 
antibodies listed in Table 6.1 to demonstrate specific proteins, features, and structures of the 
cells. List of antibodies and fluorescent dyes were provided in Table 6.1. 
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Table 6.1 List of fluorescent dyes and conjugated antibodies. 
 
Catalogue 
No. 
Dilution Chemicals Company Target 
14530 0.01 µg/mL Hoechst 33258 Sigma-Aldrich, 
Gillingham, UK 
Nucleus 
A12379 1 unit/200 
µL 
Alexa Fluor® 488 
phalloidin  
Life-technologies, 
Paisley, UK 
F-actin 
ab16667  Rabbit anti- Ki-67 
(primary antibody) 
Abcam, 
Cambridge, UK 
Nuclear localised 
proliferative cell 
marker 
ab195877 0.5 µg/mL Mouse anti-
vimentin Alexa 
Fluor® 488 
Abcam, 
Cambridge, UK 
Class III 
intermediate 
filament, 
Messenchymal 
marker 
ab24610 1 µg/mL Mouse anti-
acetylated α-
tubulin 
Abcam, 
Cambridge, UK 
Microtubule, cilia 
structure 
ab24071 0.1  µg/mL Mouse anti- Mucin 
5AC 
Abcam, 
Cambridge, UK 
Mucin 5AC, 
airway secretory 
mucous 
560061 1 µL/50  µL Mouse anti-E-
cadherin  Alexa 
Fluor® 488 
BD Biosciences, 
Oxford, UK 
E-cadherin, 
adherens junction 
ab53121 1 µg/mL Rabbit anti - 
keratin 5 
(Primary antibody) 
Abcam, 
Cambridge, UK 
Intracellular 
keratin 5, basal 
epithelial marker 
MAB3234 1  µg/mL Mouse anti-keratin 
18 
(Primary antibody) 
Millipore, 
California, USA 
Intracellular 
keratin 18, 
differentiated 
epithelial marker 
ab150116 1 µg/mL Goat anti-mouse 
Alexa Fluor® 594 
Abcam, 
Cambridge, UK 
Primary antibody 
ab150077 1 µg/mL Goat anti-rabbit 
Alexa Fluor® 488 
Abcam, 
Cambridge, UK 
Primary antibody 
ab150080 1 µg/mL Goat anti-rabbit 
Alexa Fluor® 594 
Abcam, 
Cambridge, UK 
Primary antibody 
ab150117 1 µg/mL Goat anti-mouse 
Alexa Fluor® 488 
 
Abcam, 
Cambridge, UK 
Primary antibody 
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6.2.3.1 Cell fixing and staining for histological analysis 
All cellular samples were fixed in -20
o
 C with molecular grade absolute ethanol (Sigma-
Aldrich, Gillingham, UK) for 30 minutes or up to overnight before being subjected to the 
staining process. For histological sectioning, the scaffolds were fixed in cold 4% 
paraformaldehyde (Sigma-Aldrich, Gillingham, UK) for 30 minutes or up to overnight (18h). 
6.2.3.2 Histology 
Fixed samples (n = 2 per condition) were sent to UCL IQPath (UCL, London, UK) for 
processing, scaffold sectioning and staining. Briefly, the scaffolds with cells were embedded 
in paraffin blocks and cut to 4 µm thick sections using a rotary microtome, Leica RM2235 
(Leica Microsystem (UK) Ltd., Milton Keynes, UK). The slides mounted with sections were 
deparaffinised and treated with hematoxylin and eosin (H&E) staining to indicate the gross 
morphology of the cells and periodic acid-schiff staining to identify cells with mucosal 
substances according to IQPath’s in-house protocol.  
For antibody staining, the slides obtained from IQPath must first be deparaffinised. 
Briefly, the slides were immersed in a series of xylene and ethanol (Sigma-Aldrich, 
Gillingham, UK) to remove the paraffin in the following step-by-step manner: 
  1. 1st Xylene 3 minutes 
  2. 2nd Xylene 3 minutes 
  3. 1:1 Xylene-Ethanol 3 minutes 
  4. 100% Ethanol 3 minutes 
  5. 70% Ethanol 3 minutes 
  6. 50% Ethanol 3 minutes 
  7. 30% Ethanol 3 minutes 
  8. PBS 1 minutes 
Next, the slides were gently tapped to remove excess PBS from the surrounding area of 
the section using Kimwipes (Kimberly-Clark Professional, Georgia, USA).  A circle was 
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then drawn surrounding the sections on each slide using an ImmEdge hydrophobic barrier 
pen (Vector Laboratories, Peterborough, UK) to create a small staining area and prevent 
spillage of the stain.  
The slides were stained with primary and secondary antibodies according to standard 
procedures outlined previously and were incubated in a humidified chamber to prevent 
evaporation. 
6.2.3.3 Blocking of non-specific protein binding 
After fixing, the samples were washed 2 times with 1 mL of PBS and a blocking step 
comprising of adding 1mL the blocking solution containing 1% (w/v) BSA and 0.25% (v/v) 
triton X100 in PBS was performed to reduce non-specific binding. The samples were then 
incubated at room temperature for 1 h. Next, the samples were rinsed twice in PBS washes. 
For antibody staining, the blocking solution was supplemented with an extra 10% of goat 
serum, then the same incubation and washing steps were repeated. 
6.2.3.4 F-actin cytoskeleton staining 
Following the blocking, incubating and rinsing steps, 1:200 phalloidin conjugated to  
Alexa Fluor® 488 phallotoxin (Life-technologies, Paisley, UK) was diluted in PBS and 
added to the samples, then incubated for 1h before a washing step was performed using PBS 
as previously described above. 
6.2.3.5 Antibody staining 
After each blocking step, scaffolds were washed twice with PBS. Diluted primary 
antibody (in PBS) was added to cover each scaffold (200 µL).  The samples were incubated 
at 4
o
 C overnight. The next day, the scaffolds were washed twice with 1ml PBS, the 
secondary antibody added and incubated for another 1h before carry out nuclear staining. 
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6.2.3.6 Nuclear staining 
Nuclear staining was achieved by using 0.01 µg/mL Hoechst 33258 which is a DNA 
intercalating agent (Sigma-Aldrich, Gillingham, UK) in PBS for 10 minutes as a final step in 
the staining procedure. 
6.2.3.7 Fluorescence Imaging 
The image was visualised and captured using EVOS® Imaging System (Life-
technologies, Paisley, UK) at the exposure around 20-30% of 120 ms for blue channel (Ex 
357 nm, Em 447 nm), 50-70% of 500 ms for green channel (Ex 470 nm, Em 510 nm), and 
red channel (Ex 585 nm, Em 624 nm). The images were further processed such as the cell 
count or mean area measurement using ImageJ version 1.47 (National Institutes of Health, 
Maryland, USA). 
6.2.4 Statistical Analysis 
Means and standard deviations were determined for each sampled followed by a two-way 
ANOVA analysis to evaluate the difference in protein adsorption, cell viability, proliferation, 
and cell number on each of the nanocomposite material samples. Correlation analysis was 
performed on metabolic activity and total DNA measurements. P-value < 0.05 was 
considered to be statistically significant. All statistical analysis was conducted using 
GraphPad Prism version 5.01 (2007). 
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6.3 Results 
6.3.1 Culture media adsorption and HBECs growth on microporous POSS-
PCU 
6.3.1.1 Optimisation of pre-adsorption time of cell culture media 
There was no significant difference of protein adsorption amount in TCP control, 30% 
NaHCO3, and 50% NaHCO3 scaffolds after pre-adsorption in BEpiCM culture medium for 
6h – 48h (P > 0.05) (Figure 6.2). However, M70% NaHCO3 showed a significant increase in 
adsorption over a period of 6h – 24h (P < 0.001) while there was no further adsorption from 
24h – 48h (P > 0.05). 
 
Figure 6.2 Protein adsorption of TCP and microporous POSS-PCUs over a 48h period. 
(n=4) 
6.3.1.2 HBEC’s growth on microporous POSS-PCUs 
The metabolic activity of HBEC were examined and presented in Figure 6.3. Overall, the 
metabolic activity of cells on TCP increased faster than those of microporous POSS-PCU 
samples (P < 0.001 from day 1-14). Then the metabolic activity of the TCP samples levelled 
off around day 7-11, and significantly dropped on day 11-14, probably because of reaching 
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the confluent state. For 30% NaHCO3 samples, the metabolic activity increased from day 1-7 
and levelled off on day 7-14. However, the 50% NaHCO3 samples showed a significant 
increase over the time course with the higher rate comparing to the 30% NaHCO3 samples. 
Finally, the M70% NaHCO3 presented the highest increasing rate of metabolic activity 
comparing to other POSS-PCU samples over the time course. The metabolic activity of the 
M70% NaHCO3 constantly increased and day 14 measurement was comparable to the TCP’s 
on day 4, leading to the prediction that it possibly reach the same point as TCP if the time 
course was extended. 
 
Figure 6.3 Metabolic activity of HBEC on TCP and microporous POSS-PCUs, *P < 0.5, 
**P < 0.01, ***P < 0.001, and ns = non-significant (P > 0.05). (n=6) 
Total DNA quantification of d1, d7, and d14 of each material was presented in Figure 
6.4. There were increases of DNA amount over time course in all samples (P < 0.001), 
indicating HBEC population proliferated and increased the cell number. 
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Figure 6.4 Total DNA quantity of HBEC on TCP and microporous POSS-PCUs, ***P < 
0.001, and ns = non-significant (P > 0.05). (n=3 per time point) 
Correlation of DNA amount against metabolic activity at day 1, day 7, and day 14 (Table 
6.3) was analysed to see whether the cells just increased their metabolic activity without 
proliferation or if an increase in cell proliferation caused the higher rate metabolic activity 
measured. As an R
2
 value close to 1.00 was obtained (Table 6.2), there is a direct correlation 
between the metabolic activity and rate of proliferation, meaning the metabolic activity 
increased due to a proportional increase in amount of DNA. 
Table 6.2 Correlation between metabolic activity and amount of DNA on TCP and 
microporous POSS-PCU. 
Material Correlation of metabolic 
activity and DNA 
R
2 
TCP P = 0.0016 < 0.001 1.0000 
30% NaHCO3 P = 0.0023, <0.001 1.0000 
50% NaHCO3 P = 0.0325, <0.05 0.9974 
M70% NaHCO3 P = 0.0142, <0.05 0.9995 
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To demonstrate HBECs’ cell-surface interactions with microporous POSS-PCU samples, 
F-actin staining was carried out 1 day after cell seeding. The staining showed cells flattened 
and spread on the material surfaces of both TCP and microporous POSS-PCU. Lamellipodia 
(example in greyscale window) was also seen in images where the actin micro-filaments 
protruded to the edge of cell membrane to help attachment (Figure 6.5). 
 
Figure 6.5 Primary HBECs on material surfaces (d1 post seeding) showed all cells extended 
their lamellipodia around the edge of the cells to adhere to the materials (the microfilament 
as example in greyscale window). Magnification = 400X. Scale bar = 50 µm. 
Qualitative images of basal cell marker (keratin 5, red) were assessed in HBECs in all 
samples. Every cell expressed keratin 5 (Figure 6.6). Also, there was no difference between 
HBECs on POSS-PCU samples compared with TCP controls.  
However, the quality of HBEC on each material was examined further using 
mesenchymal or proliferative markers such as vimentin and Ki-67, respectively. Total counts 
per frame and staining images at day 7 (middle stage of culture) were illustrated in Figure 
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6.7. TCP showed  higher number of cells per frame comparing to the cells on microporous 
POSS-PCU materials (P < 0.05). However, every sample showed that HBECs expressed 
vimentin (green) and Ki-67 (red), indicating proliferative populations which is relevant to 
cell viability and total DNA results with growing number of cells.  
 
Figure 6.6 Expression of keratin 5 of HBECs on d7 culture on TCP and POSS-PCUs. 
Magnification = 400X. Scale bar = 50 µm. 
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Figure 6.7 Expression of vimentin and Ki-67 of HBECs on TCP and POSS-PCUs. 
Magnification = 400X. Scale bar = 100 µm. (n=6) 
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6.3.2 Differentiation of HBECs via air-liquid interface cultures 
Normalised total DNA on material from day 1 – day 35 was illustrated in Figure 6.8. In 
all conditions, the amount of DNA increased and peaked at around d14 – d21, indicating 
cells were in a growing stage. After that, the amount of DNA gradually reduced until day 35. 
Characterisation of differentiated HBECs was investigated at specific time-point presented in 
the following results. 
  
Figure 6.8 Total DNA of HBEC cells cultured on control and POSS-PCU nanocomposite 
films over a period of 35 days. (n=4 per time point) 
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6.3.3 Characterisation of differentiated HBECs 
6.3.3.1 Gross cell morphological analysis 
Pneumacult™ differentiation medium for air-liquid interface cultures was employed to 
induce primary HBECs to form mature HBECs with functional cilia. Time-lapse images 
from day 1 – day 14 are shown in Figure 6.9. On day 1 when the cells were still cultured in 
BEpiCM, they were dispersed across the surface, as separated cells in a mono layer. After 
day 1, the medium was changed to Pnemacult™ and cells were having interactions by 
packing together with obvious reorganisation of F-actin filaments on day 7. On day 14, the 
cells had formed into a complete layer with a mature phenotype, with joining in a polygonal 
shape. At this point, the optimal point was defined to study mature morphology of HBECs. 
According to our results on total DNA, overlaid images, and company’s instruction, the 
optimal point should be around day 21 when cells developed maximum growth with 
differentiated morphology. 
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Figure 6.9 Time-lapse images of HBEC proliferation and morphology on PET and POSS-
PCU nanocomposite films Magnification = 200X. Scale bar = 100 µm. 
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6.3.3.2 Ciliated epithelia, cadherin tight junctions, and epithelial stratification. 
Scaffolds on day 21 was fixed and stained with acetylated α-tubulin which was presented 
mainly in the cilia of airway epithelium. Our results demonstrated the ciliated cells (Figure 
6.10, red) were presented in all samples and distributed across the surface. Moreover, they 
were stained with E-Cadherin (Figure 6.10, green), and confirmed that differentiated HBEC 
formed not only the shape but also the function of surface barrier cells via expression of 
cadherin junction proteins. The results were confirmed by SEM images presented in Figure 
6.11 that cells had these specific morphologies. 
 
Figure 6.10 E-cadherin staining of HBECs on PET and microporous POSS-PCU materials at 
day 21. Magnification = 400X. Scale bar = 50 µm. 
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Figure 6.11 SEM images presenting morphologic structure of cilia (*) and polygon shape of 
intercellular junction (arrow head) of differentiated HBEC (d21). Magnification = 2,000X. 
Scale bar = 10 µm.  
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Figure 6.12 Cross-sectional image of d21 epithelium on scaffolds, presenting a 
pseudostratified layer on scaffold surface and some cells migrated inside the scaffolds. 
Magnification = 400X. Scale bar = 50 µm. 
Epithelial stratification was presented in Figure 6.12. HBECs on day 21 formed a 
complete multilayer of cells with epithelial polarity, which is the fundamental feature of cells 
orientated in a vertical direction and resulting in the round or vertically oval nuclei, 
especially the apical zone.  
Also, the basal-like cells were demonstrated in the region connected to the material where 
the cells were aligned horizontally, resulting in the flat or horizontally oval nuclei. 
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6.3.3.3 Cell mucus production 
Cells on scaffold were stained with different techniques to confirm that they could 
become differentiated into goblet cells, which produce mucus- an important feature of 
pulmonary tracts. Here it demonstrated in Figure 6.14 that cells were expressing Mucin-5AC 
(red, counter stained with DAPI and E-Cadherin). Samples sectioned and treated with a 
Periodic acid-Schiff stain to demonstrate the vertical position of the goblet cells. Figure 6.13 
illustrated the presence of mucosal substances on the superficial layer, which was the correct 
position to secrete the mucus to cover epithelium. 
 
Figure 6.13 PAS staining of cross-sectional slices showed some cells on scaffolds developed 
muco-substance (magenta at arrow head) as in respiratory mucosa. Magnification = 400X. 
Scale bar = 100 µm. 
 
  
Periodic acid-Schiff staining (day 21) 
PET 
30% NaHCO3 
50% NaHCO3 
M70% NaHCO3 
100 µm 
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Figure 6.14 Specific antibody staining of scaffold on d21 confirmed that it was the 
glycoprotein Mucin 5AC that presents in respiratory tract epithelium. Magnification = 400X. 
Scale bar = 50 µm. 
6.3.3.4 HBEC migration and integration into the nanocomposite materials 
Microporous POSS-PCU scaffolds on day 35 were performed histology section and 
stained with haematoxylin and eosin to demonstrate the cell migration in to the 3D construct. 
In 30% NaHCO3, cells were limited on upper superficial surface with migration just a few 
microns below. For 50% NaHCO3, cells migrated further to attach to the pore cavity below 
and also reached the lower surface (200 – 300 µm). Finally, the M70% NaHCO3 illustrated 
the cells were also able to migrate to the lower surface with a large group of cells integrated 
inside the scaffold (Figure 6.15). 
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Figure 6.15 H&E stained sections of the scaffolds showing the degrees of migration of the 
HBECs in to the scaffolds at day 35. Magnification = 200X. Scale bar = 100 µm. 
6.3.3.5 Expression of basal cell and differentiated cell markers 
HBECs on scaffolds on day 21 and day 35 were stained with keratin 5 for basal cells and 
keratin 18 for differentiated cells to distinguish the basal layer and differentiated layer. At 
day 21, the keratin 5 (red) was mostly visible on the basal layer (cell-material interface) 
while keratin 18 was visible on the upper layer of the epithelium. However, on the M70% 
NaHCO3 some areas of the epithelium still did not have distinctive layer and cells presented 
100 µm 
Upper surface 30% NaHCO3 
M70% NaHCO3 
50% NaHCO3 
Upper surface 
Lower surface 
Upper surface 
Lower surface 
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both markers. On d35, cells became more differentiated-like by presenting more keratin 18 
while keratin 5 in the basal layer was diminished comparing to d21 (Figure 6.16). 
 
Figure 6.16 Immunofluorescent staining (keratin 5 and keratin 18) indicating the 
organisation of cells and the differences in the epithelium at day 21 and day 35 on PET and 
POSS-PCU nanocomposite films.  
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6.4 Discussion 
6.4.1 Optimisation of pre-adsorption time. 
The effects of protein adsorption examined further on cell behaviour in vitro. The level of 
protein adsorption on material affects how cell adhere and grow, so the pre-adsorption times 
were optimised. Protein adsorption on material can occur within a few seconds on 2D 
surface[138]; however, that might be different for 3D structure such as our microporous 
POSS-PCU scaffolds due to the extra luminal surface presented inside the pores. The amount 
of adsorbed protein was presented in Figure 6.2, where no significant different was found in 
TCP, 30% NaHCO3, and 50% NaHCO3. This suggested the adsorption of those 3 conditions 
had reached the saturated point after 6h; however, the M70% NaHCO3 presented continuous 
adsorption until 24h. Related back to the highest porosity and the ability to adsorb BSA in 
the previous chapters, it may be one of the reasons why the saturated point of M70% 
NaHCO3 was delayed. However, the 24h duration was chosen as the best pre-adsorption time 
to provide protein saturation on every material before starting of cell seeding. 
The protein adsorption is dynamic when including the Vroman effect and changing of 
pH. Vroman effect occurs when the random types of proteins will adsorb on the surface and 
later, followed by the replacement of higher affinity proteins[142]. Therefore, the lower 
affinity ones will be released back in to bulk solution. The other effect might be the pH 
changing of the cell culture medium because Sharpe et al. demonstrated different pH altered 
different amount of protein adsorption on the material[157]. Therefore, the deeper studies on 
protein-material interaction need to be investigated in the future to explain the process, 
especially when the materials come into contact with human serum or blood. 
6.4.2 HBECs attached and grew on microporous POSS-PCU over 14 days with 
expression of CK5, vimentin, and Ki-67. 
The cell viability measurement via metabolic activity revealed cells significantly grew in 
all POSS-PCU samples but slower than TCP control. The M70% NaHCO3 had higher cell 
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metabolic activity than 30% and 50% NaHCO3 (P < 0.001) and constantly increased over 14 
days of measurement. In addition, it was comparable to the TCP’s on day 4, leading to the 
prediction that it possibly reach the same point as TCP if the time course was extended. To 
confirm that cells also proliferated and not just increase in metabolic activity, total DNA 
contents were evaluated on day 1, day 7, and day 14, and compared the correlation with 
metabolic activity. The correlation analysis showed that total DNA amount relatively 
increased when metabolic activity increase (P < 0.05). This suggested the DNA amount was 
also increasing due to the cell proliferation, resulted in metabolic activity was getting higher. 
The cell markers were additionally explored, which are filamentous actin, keratin 5, vimentin 
and Ki-67, respectively, to explain cell behaviour on the material. 
The ability of cells to respond to external environment relies on the coordinated 
disassembly and assembly of cytoskeleton filamentous actin (F-actin). This ability is critical 
for various cell functions including adhesion, wound healing, division, and locomotion[158]. 
Furthermore, cells can mechanically sense their local environment, as they spread more, and 
migrate to the stiffer substrates[158]. In particular, networks of F-actin and its protein cross-
linkers have been implicated as major contributors to the mechanical properties of the 
cell[159]. Our results showed HBECs spread on microporous POSS-PCU surface in the 
similar way to the TCP control. In addition, lamellipodia structures were presented in all 
cells by protruding out around the edge of cytoplasm which indicated HBECs had 
interactions with the material leading to cell attachment. 
Keratin 5 was employed to characterise basal-cell phenotype of HBECs which has the 
ability to differentiate in to mature phenotype later on[160]. Cells on material on d7 were 
further assessed to prove that the cells still express basal cell marker. It was demonstrated 
that all cells expressed keratin 5 and did not have significant difference between POSS-PCU 
conditions and TCP control. Also, other markers were used to explain the growth of cell 
population which are Ki-67 and vimentin. 
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Ki-67 is a human nuclear protein which is expressed strictly in association with cell 
proliferation and which is routinely used in pathology as a "proliferation marker"[161]. The 
Ki-67 protein presents during all active phases of the cell cycle such as G1, S, G2, and 
mitosis, but is absent from resting cells at G0, makes it a good marker to define the growing 
cells of a given population[162]. Vimentin is a type III intermediate filament protein that is 
expressed in mesenchymal cells and plays significant role in supporting organelle location in 
the cytosol by attaching to the nucleus, endoplasmic reticulum, and mitochondria, either 
laterally or terminally[163]. However, there was evidence that vimentin was co-expressed 
with keratin in the basal part of human nasal epithelium[164]. Vimentin also helped 
maintenance cell mechanical properties and integrity of the cytoplasm, as well as the 
resilience of the other cytoskeletal systems[165]. Therefore, HBEC characterisation using 
vimentin was carried out in addition to Ki-67.  
HBECs on materials in each condition on day 7 were immuno-stained with anti-vimentin 
and anti-Ki-67 (Figure 6.7). It demonstrated that microporous POSS-PCU expressed 
vimentin and Ki-67 but was relatively low compared to the TCP positive control (P < 0.05). 
This might explain by the lower cell viability and total DNA on day 7 of microporous POSS-
PCU samples that exhibited lower new population of HBECs. Overall, 3D POSS-PCU, 
which has great potential for regenerative medicine, needs to be tested in further detail using 
appropriate system to show us the differences between it 2D material. 
6.4.3 HBECs grew and differentiated on microporous POSS-PCUs under air-
liquid interface culture 
The air-liquid interface technique (ALI) was employed to study the differentiation of 
primary HBEC to a pseudostratified columnar epithelial layer. Cell seeding at confluent state 
was performed to make sure the cells cover all the entire surface of scaffold material. A 
Transwell® insert was employed as positive control as it has been the gold standard material 
for epithelial culture and differentiation in vitro[166–169]. Because the culture area of PET 
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insert and POSS-PCU insert were different, the total DNA data were normalised to per cm
2
 
to make them comparable. Normalised total DNA showed the cells had grown from day 1 to 
day 14 and peaked around day 14 to day 21. After that, the total DNA amount had declined 
until termination of the experiment at day 35, which suggests that the maximum growth 
takes place between day 14 and day 21. Figure 6.9 showed the remarkable changing of F-
actin organisation of HBEC when BEpiCM was replaced with differentiation medium 
(Pneumacult™). HBECs had more cell interaction, packed together, and formed a complete 
layer with a net-like mesh work which is the morphology of epithelial cells[170,171].  
Cells on all materials were positive when stained with anti-acetylated α-tubulin and anti-
E-cadherin. Acetylated α-tubulin is presented mostly in cilia in ciliated cell[172,173] and E-
cadherin is junction adherent proteins that connect epithelial cells together to form a 
barrier[174–176]. Cells on both PET and POSS-PCU scaffolds expressed these proteins and 
it was also confirmed by SEM images that cells had intercellular junctions. Moreover, the 
cross-sectional H&E images demonstrated the organisation of pseudostratified layer with 
epithelial polarisation which is the important characteristic of tissue-engineered 
epithelium[177,178]. Another characteristic of airway epithelial cells is mucin production. 
Mucin is the gel-like substance that is produced from goblet cell to keep the moisture, and 
protect the infection or chemicals[80,179–181]. It was confirmed that the differentiated 
HBECs on both PET and POSS-PCU material produced mucin at the apical layer via PAS 
and anti-Muc 5AC staining.  
The further examination of the vertical migration on microporous POSS-PCU scaffolds 
also revealed the cells migrated through the thickness of 50% and M70% NaHCO3 scaffolds. 
However, the 30% NaHCO3 showed the cells were accumulated on the surface with only a 
few microns of migration. This incident suggested the permeability of the scaffold also had 
an influence on the cell migration on different porosities of microporous POSS-PCU 
scaffolds. The best porosity for the scaffold remains unanswered because another aspect such 
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as the neovascularisation after implantation is needed for mucosal regeneration[155]. Also, 
the control of epithelial to just the superficial layer is important to get the right mucosal 
structure and avoid unwanted integration to the material[152]. The future studies such as co-
culture, material coating and in vivo implantation, might give more information to help 
decide the right porosity for controlling mucosal structures. 
Keratin 5 and keratin 18 were employed to differentiate basal cell and differentiated cell, 
respectively[79,160,172]. HBECs on PET and POSS-PCU material on d21 presented keratin 
5 expressed mostly in the basal layer while slightly expression of keratin 18 was found on 
the apical layer. However, on later d35, the cells expressed more keratin 18 throughout 
epithelial layer with diminishing trend of keratin 5 expression in the basal region. This 
relevant to the reduction of total DNA amount on d35 that might affect by the reduction of 
proliferative basal cells population and becoming more differentiated type as indicated in 
keratin staining. 
In conclusion, the experiment illustrated the success of regenerating artificial airway 
epithelium on microporous POSS-PCU material for the first time, with the growth and 
characteristic of artificial epithelium comparable to in vitro gold standard Transwell® insert. 
This model could represent the real interactions between HBECs and POSS-PCU material 
under in vitro condition and could be used as a base-line for further development and 
functionalisation to enhance the material properties. 
6.5 Conclusion 
This chapter demonstrated the success of regenerating in vitro artificial airway epithelium 
on microporous POSS-PCU scaffolds. The differentiated epithelial cells had epithelial 
characteristics such as cilia, junction adherens, pseudostratification, and mucin production. 
The material showed comparable cell growth and differentiation ability to the commercial 
Transwell® insert but with additional migration and integration of cells due to its 3D porous 
structure. Microporous POSS-PCU could be useful for further in vivo study for tissue 
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integration and angiogenesis in the future and presented the great potential to be developed 
for laryngotracheal application as well as other epithelial-derived organs. 
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Chapter 7 Human bone-marrow 
mesenchymal stem cell culture 
and in vitro chondrogenic 
differentiation on microporous 
POSS-PCU scaffold 
7.1 Introduction 
The fields of regenerative medicine and tissue engineering address the replacement of 
organs and tissues due to clinical trauma, disease or congenital defect. Biomaterial scaffolds 
are intended to facilitate the construction of a biomimetic environment to enhance cell 
growth and differentiation[182]. While somatic cells, such as osteoblasts and chondrocytes, 
were the first to be used in bone and cartilage tissue-engineering, the more recent addition of 
stem cells to tissue engineering has extended its therapeutic potential[183]. Among adult 
tissue-derived stem cells, mesenchymal stem cells (MSCs) have been extensively studied, 
due to their ease of expansion and multipotency for differentiation into cells of myogenic, 
osteogenic, and the chondrogenic cell lineage[184]. 
MSCs became an attractive cell source for clinical therapies because the cells could be 
isolated with relative ease from multiple sources, including bone marrow, fat and skeletal 
tissue[183]. Bone-marrow mesenchymal stem cells (BM-MSCs) are attractive candidates for 
laryngotracheal regeneration[185] due to its capability in tissue remodelling, and reduction 
of fibrosis and scars[73,76,77]. In addition, they share cell surface antigen expression with 
vocal fold fibroblasts, which are the main population involved laryngeal epithelial response 
to injury[186]. BM-MSCs seeded on 3D scaffolds helped generate extracellular matrix by 
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remodelling the surrounding tissue better than the non-seeded scaffolds in recent in vivo 
laryngeal tissue engineering studies[187,188].  
POSS-PCU materials have shown great promise in cartilage tissue engineering studies. 
Oseni et al. demonstrated that when chondrocytes were cultured on POSS-PCU scaffolds, 
extracellular matrix components such as sGAG and collagen were generated[189]. POSS-
PCU scaffolds also facilitated the growth of human adipose tissue-derived stem cell 
(hADSC) and chondrogenic differentiation into cartilage[190]. In this chapter, the potential 
of microporous POSS-PCU was explored to support BM-MSCs in terms of 
cytocompatibility, growth, and chondrogenic differentiation. This is to test its feasibility for 
future repair of laryngotracheal defects.  
 
7.2 Materials and methods 
7.2.1 BM-MSC culture and seeding 
BM-MSCs were subcultured and expanded with Mesenchymal Stemm Cell Medium, 
MSCM (Sciencell, California, USA), in T75 cm
2
 flask according to section 3.7.2 and 3.8. 
Before seeding, T75 cm
2
 flask with a confluent layer of BM-MSCs was washed with 10 mL 
sterile PBS (20 mM). After washing, PBS was aspirated using a serological pipette and 3 mL 
of 0.25% trypsin-EDTA (Life-technologies, Paisley, UK) was added to the flask and allowed 
to incubate at 37
o
 C for 3 min until the cells can be detached with gentle tapping at the side 
of the flask. Then, 3 mL of trypsin was neutralised by adding 7 mL of fresh MSCM. The cell 
suspension was transferred in to a 15 mL centrifuge tube, and spun at 1,200 rpm for 5 min to 
concentrate the cell population. After centrifugation, the supernatant was discarded, and the 
cell pellet was resuspended in 2 mL of fresh MSCM. A viable cell count was performed 
using Trypan Blue staining, and haemocytometer to determine the amount of live cells using 
the Trypan Blue exclusion assay. Approximately 5 X 10
4
 cells/mL were seeded on to each 
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well of a 24 TCP plate containing microporous POSS-PCU, which had been preadsorbed 
with 1 mL of MSCM after 24h prior to cell seeding. 
 
7.2.2 Cell viability and proliferation of BM-MSCs on microporous POSS-PCU 
scaffold 
The viability of BM-MSCs on POSS-PCU materials and TCP controls was tested using 
Alamar Blue™ assay for cell metabolic activity at time point of day 1, 4, 7, 11 and 14, as 
described previously in section 3.9. Cell proliferation was measured by freeze-and-thaw of 
the scaffold to extract their total DNA and using Hoechst 33258 fluorescent dye at time 
points of day 1, 7 and 14 via the methods described in detail in section 3.10.    
7.2.3 Immunofluorescence staining 
After fixing the cells in cold absolute ethanol, the samples were washed twice with 1 mL 
of sterile PBS. In blocking step, 1mL of blocking solution (1% (w/v) BSA and 0.25% (v/v) 
triton X100) in PBS was added to reduce non-specific protein binding. The samples were 
incubated at room temperature for 1 h. 
After blocking, the samples were rinsed twice with PBS, and 1:200 phalloidin Alexa 
Fluor® 488 (Life-technologies, Paisley, UK) diluted in PBS and was added into each 
sample. The incubation was performed at room temperature for 1 h, followed by rinsing 
twice with PBS as described previously. Finally, nuclear staining was achieved by using 0.01 
µg/mL Hoechst 33258 (Sigma-Aldrich, Gillingham, UK) in PBS for 10 min as a final step in 
the staining procedure. 
The image was visualised and captured using EVOS® Imaging System (Life-
technologies, Paisley, UK) at the exposure around 20-30% of 120 ms for blue fluorescence 
(Ex 357 nm, Em 447 nm), 50-70% of 500 ms for green fluorescence (Ex 470 nm, Em 510 
nm). 
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7.2.4 Chondrogenic differentiation of BM-MSCs on microporous POSS-PCUs 
7.2.4.1 Chondrogenic differentiation 
Human BM-MSCs were subcultured in T75 cm
2
 flask supplemented with MSCM 
medium (Sciencell™ Research Laboratories, California, USA) according to section 3.7.2 and 
3.8. BM-MSCs were typsinised and seeded on to each material as previously described in 
7.2.1 with 1mL of MSCM medium as detailed in Table 7.1. 
Table 7.1 BM-MSC culture conditions and assessment 
 
Chondrogenic differentiation was carried out on day 1 post seeding. Briefly, MSCM 
medium was discarded and replaced with 1 mL of Mesenchymal Stem Cell Chondrogenic 
Differentiation Medium (MCDM) supplemented with chondrogenic differentiation 
supplement, 5% penicillin/streptomycin (Sciencell™ Research Laboratories, California, 
USA), and 10 ng/mL Transforming growth factor beta-3(TGF-β3) (Miltenyi Biotec Ltd., 
Surrey, UK). Fresh MCDM was replaced in every third day of culture according to the 
company’s instruction throughout the 5-week culture. TCP and microporous POSS-PCU 
samples were collected at day 1, 7, 14, 21, 28, and 35 to study sGAG synthesis and DNA 
Sample Seeded 
cell/sample 
Material sGAG 
quantification 
DNA 
quantification 
Histology 
assessment 
Chondrogenic 
spheroids 
1 X 10
6 
15 mL 
polypropylene 
centrifuge 
tube 
  ✓ 
Tissue 
Culture 
Polystyrene 
(TCP) 
5 X 10
4 
24-well plate 
 
 
✓ ✓  
Microporous 
POSS-PCUs 
5 X 10
4
 1.6 mm 
Microporous 
POSS-PCU 
discs of 30%, 
50% and 
M70% 
NaHCO3 
✓ ✓ ✓ 
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content. Chondrogenic spheroids and POSS-PCU samples on day 28 were used in histology 
assessment to study ECM forming with H&E, Alcian Blue, and van Gieson staining. 
7.2.4.2 Assessment of sulfated glycosaminoglycan (sGAG) synthesis 
Sulfated glycosaminoglycan is one of the main components for structural integrity of 
cartilage[191]. Current well-established protocol for BM-MSCs differentiation allows us to 
investigate the differentiation process of BM-MSCs to chondrogenic lineage with cartilage-
like ECM production in vitro[192]. TCP and microporous POSS-PCUs were seeded with 5 
X 10
4
 cells per sample  and a change of MSCM medium to MDCM chondrogenic 
differentiation medium was carried out day 1 post seeding as previously described in section 
7.2.4.1. The equal sets of samples were still maintained in MSCM medium to use as negative 
controls for non-differentiation state of BM-MSCs on each material. The arrangement of 
sample number was illustrated in Table 7.2. 
Table 7.2 Number of samples in each condition per time point for sGAG and DNA 
quantification studies. 
Material Non-differentiated BM-MSCs 
(per time point) 
Differentiated BM-MSCs 
(per time point) 
sGAG 
quantification 
DNA 
quantification 
sGAG 
quantification 
DNA 
quantification 
TCP N = 4 N = 4 N = 4 N = 4 
30% 
NaHCO3 
N = 4 N = 4 N = 4 N = 4 
50% 
NaHCO3 
N = 4 N = 4 N = 4 N = 4 
M70% 
NaHCO3 
N = 4 N = 4 N = 4 N = 4 
 
7.2.4.2.1 Papain pre-extraction 
TCP and microporous POSS-PCU samples (N = 4 per condition) were pre-extracted on 
day 1, 7, 14, 21, 28, and 35 using papain extraction reagent according to the company’s 
instruction (Biocolor Ltd., Antrim, UK). Briefly, 50 mL of 0.2M sodium phosphate buffer, 
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pH 6.4 was prepared by dissolving 400mg sodium acetate, 200 mg EDTA disodium salt, and 
40 mg cysteine HCl together in deionised water. Papain enzyme at 0.1 mg was introduced to 
every 1 mL of 0.2M sodium phosphate buffer to make a complete extraction reagent. All 
chemicals in this step were purchased from Sigma-Aldrich (Gillingham, UK). Each sample 
was added with 500 µL of extraction reagent and incubated at 65
o
 C for 3 h with occasional 
mixing. After 3 h, the extracted solutions were transferred to 1.5 mL micro-centrifuge tubes 
and spun at 10,000g for 10 min to remove the debris from the solution. Retain supernatants 
were used in sulphated glycosaminoglycan quantification and DNA quantification[193]. 
7.2.4.2.2 Sulfated glycosaminoglycan (sGAG) quantification 
Sulfated glycosaminoglycan was quantified using Blyscan™ sulphated 
glycosaminoglycan assay (Biocolor Ltd., Antrim, UK). Extracted suspensions from 7.2.4.2.1 
of 250 µL were transferred to new micro-centrifuge tubes and 1 mL of Blyscan dye reagent 
was added into each tube (n=4 per condition). The tubes were placed on a gentle mechanical 
shaker for 30 minutes. During this period, sGAG-dye complex formed and precipitated out 
from the soluble unbound dye. Then, the tube was spun at 12,000 rpm for 10 min and the 
supernatant was carefully removed. 0.5 mL of dissociation reagent was added to the pellet 
with interval mixing in vortex to help resuspend the sGAG-dye complex. Finally, 200 µL of 
each suspension was transferred to a clear 96-well plate and read the absorbance at 630 nm 
using a microplate reader (Biotek, Swindon, UK). The absorbance was calculated using a 
standard curve generated from glycosaminoglycan standards provided with the kit and was 
corrected with a dilution factor of 2. 
7.2.4.2.3 DNA quantification 
DNA quantification (n = 4 per condition) was also carried out to demonstrate the cell 
proliferation and the ratio of sGAG per DNA. Extracted suspension from 7.2.4.2.1 of 100 µL 
was mixed with 100 µL of 1 µg/mL Hoechst 33258 (Sigma-Aldrich, Gillingham, UK) in 
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black 96-well plate. The plate was read the fluorescence at 380 nm excitation and 420 nm 
emission using the Fluoroscan Ascent FL (Thermo Fischer Scientific, Massachusetts, USA). 
The data were compared to standard curve generated from standard calf thymus DNA 
provided with the kit and were corrected with dilution factor of 5. 
7.2.4.3 Histology 
Chondrogenic spheroids (day 28), non-differentiated BM-MSC on POSS-PCUs (day 14 
and 28), and differentiated BM-MSC on POSS-PCUs (day 28) were fixed in 4% PFA in 
saline buffer (n = 2 per condition). Samples were sent to UCL Institute of Neurology 
(London, UK) to process the sample sections prior to staining. Briefly, the samples with cells 
were embedded in a paraffin block and cut in to 4 µm-thick sections using rotary microtome, 
Leica RM2235 (Leica Microsystem (UK) Ltd., Milton Keynes, UK). The slide gross sections 
were deparaffinised and stained with haematoxylin and eosin (H&E) stain, to indicate the 
gross cell morphology. The cartilage-like ECM production was investigated using Alcian 
Blue staining for polysaccharide (e.g. glycosaminoglycans) and van Gieson staining for 
collagen indication. 
7.2.5 Statistical analysis 
The mean and standard deviation data were compared using a two-way ANOVA to 
evaluate the difference of cell viability, cell proliferation, and sGAG quantification between 
materials with post hoc tests using Bonferroni’s multiple comparisons test on each time 
point. P-value ≤ 0.05 was considered statistically significant between control and test 
samples. All statistical analysis was performed on the data sets using GraphPad Prism 
version 5.01 (2007) (GraphPad Software, Inc., California, USA).  
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7.3 Results 
7.3.1 Cell viability of BM-MSCs on microporous POSS-PCU scaffold 
Metabolic activity of BM-MSCs on both TCP and microporous POSS-PCUs (Figure 7.1) 
showed a linear increase over 14 days of experiment (P ≤ 0.001). BM-MSC on TCP control 
had a significant higher metabolic activity than the microporous group from day 4 to 14 
comparing based on each time point (P ≤ 0.001). However, there was no significant 
difference in the trend when comparing 30%, 50% and M70% microporous POSS-PCUs (P 
> 0.05 for each time point, day 1-14). 
 
Figure 7.1 Metabolic activity of BM-MSCs on TCP and microporous POSS-PCU materials 
on day 1 to day 14. (n=6) 
Total DNA quantification of BM-MSCs on TCP and microporous POSS-PCUs (Figure 
7.2) also demonstrated an increase from day 1 to day 14 with linearity (P ≤  0.001). Similar 
to metabolic activity, the total DNA of TCP was significantly different from the microporous 
134 
 
POSS-PCUs when comparing each time point (P ≤ 0.001). However, there was no 
significant difference in the microporous group comparing each time point (P > 0.05). The 
increasing of DNA content from each time point in all materials also correlated with the 
increase of metabolic activity (P ≤ 0.001), suggesting the cell population was proliferating 
on the material. 
 
Figure 7.2 Metabolic activity of BM-MSCs on TCP and microporous POSS-PCU materials 
on day 1 to day 14. (n=3 per time point) 
F-actin staining (Figure 7.3) and H&E staining (Figure 7.4) of BM-MSCs on TCP and 
microporous POSS-PCU presented a nearly confluent state on the surface. The cells were 
packed and elongated across the surface in almost a mono layer. 
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Figure 7.3 F-actin staining of BM-MSCs on TCP and microporous POSS-PCU surface on 
day 14 of culture. 
 
Figure 7.4 H&E staining of BM-MSCs on cross-sectioned microporous POSS-PCU surface 
on day 14 of culture. 
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7.3.2 Chondrogenic differentiation of BM-MSCs on microporous POSS-PCUs 
7.3.2.1 Sulfated-glycosaminoglycans (sGAG) synthesis 
Validation of Blyscan™ on sGAG quantification using standard glycosaminoglycan is 
illustrated in Figure 7.5. The absorbance at 630 nm and amount of sGAG from 0 – 6 µg 
showed a linear relationship (P ≤ 0.01) with R2 = 0.997. This standard curve was also used to 
calculate the amount of sGAG on each material in subsequent experiments. 
 
Figure 7.5 Linearity of sGAG quantification 
Total sGAG syntheses of non-differentiated and differentiated BM-MSCs on all materials 
are presented in Figure 7.6. The patterns of sGAG synthesis were similar in all materials. 
Non-differentiated BM-MSCs on all materials exhibited an increase on day 1-14 and plateau 
out on day 14 -35. Differentiated BM-MSCs on all materials demonstrated different trends 
with an exponential increase on day 1-14, reaching the plateau around day 14-28, and the 
decrease from day 28-35. The mean sGAG syntheses of non-differentiated BM-MSCs were 
significantly different from differentiated BM-MSCs in all materials from day 7-35 (P ≤ 
0.01). 
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Figure 7.6 Total sGAG quantification of non-differentiated and differentiated BM-MSCs on 
TCP and microporous POSS-PCU materials. (n=4 per time point) 
Total DNA quantification demonstrated in figure showing an increase on day 1-14 and 
plateau out on day 14-35 of culture in both non-differentiated and non-differentiated 
conditions (Figure 7.7). The Bonferroni’s comparisons at each time point indicated that there 
was no significant difference between non-differentiated and differentiated BM-MSCs on all 
materials (P > 0.05). 
 
Figure 7.7 Total DNA quantification of non-differentiated and differentiated BM-MSCs on 
TCP and microporous POSS-PCU materials. (n=4 per time point) 
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The ratio of sGAG/DNA is illustrated in Figure 7.8. The sGAG/DNA ratios of non-
differentiated BM-MSCs in all materials demonstrated an almost constantly straight line over 
5 weeks of culture with no significant difference (P > 0.05), despite the increase of 
proliferation indicated by total DNA. However, differentiated BM-MSCs in all materials 
showed a significant difference of sGAG/DNA ratio comparing to the non-differentiated 
samples (day 7-35, P < 0.01), suggesting the extra amount of sGAG was produced in 
differentiated samples over the 5-week culture. 
 
Figure 7.8 Ratio of sGAG/DNA of non-differentiated and differentiated BM-MSCs on TCP 
and microporous POSS-PCU materials. (n=4 per time point) 
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7.3.2.2 Morphological characterisation via histology 
7.3.2.2.1 Cell Spheroids 
Chondrogenic differentiation assay on day 28 demonstrated cells aggregated and formed 
a spherical structure with production of fibrous-like features around the spheroid (Figure 
7.9). Three techniques of staining were employed to differentiate the characteristics of 
spheroids and they presented the expected outcome of positive chondrogenesis. H&E 
staining revealed a bi-layer of spheroid construct, which the aggregations of cells were inside 
and the outside covered with denser fibrous-like structure with the cells embedded within the 
spheroids. GAG production throughout the spheroid was confirmed by Alcian Blue staining 
whereas Van Gieson staining revealed the collagen was produced only at the covered 
fibrous-like layer. These results were used as a positive control to demonstrate the success of 
differentiation protocol, and were compared with the differentiation of BM-MSCs on 
microporous POSS-PCU materials.  
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Figure 7.9 Chondrogenic spheroid differentiated from BM-MSCs after 28 days stained by 
H&E (a and b), Alcain Blue (c and d), and Van Gieson’s staining (e and f). Magnification = 
100X and scale bar = 500 µm (a, c, and e). Magnification = 400X and scale bar = 100 µm (b, 
d, and f). 
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7.3.2.2.2 Cells on POSS-PCU materials 
H&E staining of undifferentiated and differentiated BM-MSCs on microporous POSS-
PCU (day 28) is shown in Figure 7.10. Negative controls show BM-MSCs maintained 
almost a mono-layer of cells on each material while differentiated cells present a thicker 
multi-layer of cells with ECM to about 70 – 120 µm. 
 
 
Figure 7.10 H&E staining of non-differentiated BM-MSCs (left panel) and differentiated 
chondrogenic-like cells (right panel) after 28 days on microporous POSS-PCU materials. 
Magnification = 400X and scale bar = 100 µm. 
Alcian Blue staining (Figure 7.11) revealed more details of GAG deposition pattern 
between undifferentiated and differentiated BM-MSCs. Undifferentiated BM-MSCs 
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(negative control) on all microporous POSS-PCU materials organised into a thin layer of 
cells (red/pink colours) on top of the materials with no or very little GAG deposition (blue 
colour) in extracellular space, whereas the differentiated chondrogenic-like cells exhibited a 
multi-layer of cells with a significant deposition of GAGs in the extracellular space. The 
constructs were fibrous-like and similar to that of the outer layer of spheroid positive control, 
where the fibrous-like structure was integrated with cells. However, the differentiated cells 
on POSS-PCU materials did not form spheroid structures similar to those of the positive 
control. Instead, they spread and aligned along the surface of the microporous POSS-PCU. 
 
Figure 7.11 Alcian Blue staining of non-differentiated BM-MSCs (left panel) and 
differentiated chondrogenic-like cells (right panel) after 28 days on microporous POSS-PCU 
materials. Magnification = 400X and scale bar = 100 µm. 
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Van Gieson’s staining (Figure 7.12) demonstrated the similar pattern to the Alcian Blue 
staining. Undifferentiated BM-MSCs in all microporous POSS-PCU studies organised in a 
thin layer of cells (dark brown/brown colours) on top of the materials without collagen 
deposition (pink colour) in the extracellular space while the differentiated chondrogenic-like 
cells exhibited a multi-layer of cells with a significant deposition of collagen in extracellular 
space. 
 
Figure 7.12 Van Gieson staining of non-differentiated BM-MSCs (left panel) and 
differentiated chondrogenic-like cells (right panel) after 28 days on microporous POSS-PCU 
materials. Magnification = 400X and scale bar = 100 µm. 
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7.4 Discussion 
Cytocompatibility studies of microporous POSS-PCU were presented with human 
bronchial epithelial cell in chapter 6. In this chapter, the response was investigated in the 
same material using human bone-marrow mesenchymal stem cells (BM-MSCs), both 
differentiated and undifferentiated, with a view to assessing potential use of this combination 
in tissue engineering applications. 
Fourteen days culture of BM-MSCs on TCP, 30%, 50% and M70% NaHCO3 
microporous POSS-PCUs demonstrated a linear growth over 14 days of culture indicated by 
the increase of both metabolic activity and DNA content. Nuclear, f-actin and H&E staining 
on day 14 demonstrated the BM-MSCs formed a confluent layer on TCP and microporous 
POSS-PCU. 
Differentiation of BM-MSCs to chondrogenic lineage using a well-established protocol 
was performed and the behaviour of these cells examined on microporous POSS-PCU to 35 
days of culture. Phenotype was measured indirectly via cartilaginous extracellular matrix 
production over the culture period. The behaviour of differentiated BM-MSCs was 
quantitatively measured by sGAG production and qualitatively by histochemical evidence of 
deposition of ECM, GAG, and collagen. 
The production of sGAG in differentiated BM-MSCs on all materials was significantly 
different between days 7 and 35 (P ≤ 0.01) from that of undifferentiated BM-MSCs. The 
ratio of sGAG/DNA exhibited the same trend (P ≤ 0.01) while that of undifferentiated 
samples was constant throughout 35 days, despite progressive cell proliferation in both 
conditions. This suggested the differentiated samples produced more sGAG. Histology of 
day 28 samples (time point of maximum production) demonstrated location of sGAG 
deposition. 
Chondrogenic spheroids (day 28) were used as positive control for histochemistry 
because of the facility with which they can be micro-sectioned. An aggregation of cells and a 
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visible spheroid construct was formed over 28 days and gave a circular shape when it was 
micro-sectioned. A distinctive 2 layer-structure was revealed by H&E: dense outer layer of 
cellularised fibrous-like structure; less dense inner layer composed of cells only. Alcian Blue 
staining showed blue colour throughout, more so in the outer layer, indicating GAG 
production. Van Gieson staining showed an outer layer composed of red-coloured collagen 
fibres, suggestive of ECM deposition, with cells throughout both layers. 
Chondrogenic differentiation of BM-MSCs on microporous POSS-PCU materials 
revealed a combination ECM and cell layer spread across the material surface whereas the 
undifferentiated samples showed a thin layer of cells without significant ECM production. 
H&E staining of differentiated samples showed a thick layer of fibrous-like ECM with cells 
embedded inside, whilst undifferentiated samples were composed of thin confluent cell 
layers on the material surface. Alcian Blue and van Gieson staining showed similar structure 
of GAG layers with cells and collagen layers with cells, respectively, whereas the 
undifferentiated samples did not have a significant “ECM” component. 
This experiment suggests that BM-MSCs can be grown and differentiated on 
microporous POSS-PCU materials. The difference in morphology between differentiated and 
undifferentiated samples may relate to the sGAG/DNA ratio results. The significant 
difference in sGAG/DNA ratio between undifferentiated and differentiated samples might be 
due to the extra deposition of sGAG in the extracellular space in differentiated samples and 
was confirmed by staining pictures. However, more studies could be further carried out in 
the future to gather more evidences by detection of cell surface antigen or gene expression 
such as CD44, CD54, collagen type II, and aggrecan[194–196]. 
Microporous POSS-PCU appears to support BM-MSC growth and chondrogenic 
differentiation in vitro. In this study, the same material was employed as in previous studies 
of human bronchial epithelial cells. The results showed the chondrogenic-like mass 
aggregates mainly on the top of microporous surface with low permeation into the pores. The 
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pore size used was 25 – 53 µm, a size previously shown to support epithelial growth. 
However, a different pore size may be required to optimise and promote MSC-chondrocyte 
integration. A pore range of 100 – 300 µm in 3D porous poly(epsilon-caprolactone) and silk-
fibroin scaffolds has been described to better facilitate cell infiltration, chondrogenic or 
osteogenic differentiation of human BM-MSCs, resulted in uniform matrix formation across 
the depth of the scaffolds, possibly for its micro-architechture reasons[197–199]. There are 
also limitations to using ECM-production alone as a marker of chondrocytic differentiation. 
More detailed characterisation of these cells might include measurement of gene expression, 
detailed immunophenotyping or cytokine production[194–196].  
7.5 Conclusion 
Microporous POSS-PCU supported BM-MSC growth and probable chondrogenic 
differentiation in vitro with sGAG and collagen production mimicking ECM. Further in vivo 
studies of POSS-PCU are warranted to confirm safety and potential efficacy as a scaffold 
material for laryngotracheal tissue engineering.  
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Chapter 8 Summary and Future 
Outlook 
Functional laryngeal replacement would be life-changing for patients who undergo total 
laryngectomy or suffer from severe structural airway disorders. The treatment for 
laryngectomised patients has not changed for decades[2]. Commercially available implants 
for total laryngectomies such as Montgomery T tube[200], and Provox[201], allow patients 
to breathe through open tracheostoma. However, current laryngeal implants are unable to 
meet all functional needs due to their suboptimal voice function and tissue integration in 
particular[202,203]. Therefore, researchers are currently investigating using tissue-
engineering and regenerative medicine approaches to improve the quality and function of 
laryngeal implants to match these clinical needs. 
A novel nanocomposite with enhanced physiochemical properties and superior biological 
stability has been developed by our group. Formed by incorporating polyhedral oligomeric 
silesquioxane (POSS) into poly(carbonate-urea) urethane, POSS-PCU may offer new 
potential for the development of a new generation of  laryngeal implants, due to its superior 
mechanical properties and biocompatibility than current industry standard materials such as 
ePTFE[204]. POSS-PCU is currently in use for a range of tissue engineering applications 
and has been successfully implanted in human in the form of a small calibre cardiac bypass 
graft[83], lacrimal duct conduit[71], and more recently as the basis of a synthetic 
trachea[30]. 
Chapter 4 demonstrated that the solvent evaporation technique (casted POSS-PCU) and 
phase inversion/particulate leaching technique (microporous POSS-PCU) allow the 
manufacture of customised POSS-PCU laryngeal implants that replicate the shape of a 
porcine larynx. The materials produced have similar structural and mechanical properties 
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compared to a porcine larynx (cartilage and epithelium). The key findings were that non-
porous casted POSS-PCU had closer elastic moduli to porcine cartilage while that of 
microporous POSS-PCU was closer to that of epithelium. This evidence suggested that 
POSS-PCU may be tailored to suit diverse tissue-replacement needs. Casted POSS-PCU can 
be used to provide the integrity of the whole implant to keep the hollow tube open and 
prevent stenosis while the microporous POSS-PCU fully coated outside, might be used for 
cell growth and tissue integration with re-epithelialisation, as well as reduced graft extrusion. 
A previous in vivo study of an implant composed of casted POSS-PCU coated with 
microporous POSS-PCU (one-side coated) in pigs showed that the grafts extruded after 
implantation (Lange, personal communication). Histology revealed that contacted casted 
non-porous POSS-PCU did not demonstrate good tissue integration at the anastomosis site. 
Thus, the study on fully coated microporous POSS-PCU was chosen. 
Microporous POSS-PCU was tested as a candidate material to replace the vocal cords, 
and in this setting produced comparable ‘voice’ in a controlled air-flow system. The 
generated sound quality was similar to that of the human voice regarding fundamental 
frequency and sound energy. Pitch (fundamental frequency) was varied by a change in 
material thickness and strain, whereas sound energy could be increased or decreased by 
controlling airflow. In this model, it illustrated the superior quality of sound generated 
compared to that of a recent clinical titanium implant[2]. However, this model has some 
limitations that can be improved in the future. The additional apparatus such as temperature-
humidifier[101–103] can be integrated into the testing system to control the condition 
instead of the ambient temperature and moisturised air employed in our experiment. How 
such cords may be made to move to fulfil the needs of speech, breathing, coughing and 
airway protection remain to be determined. The potential roles of pneumatic artificial 
muscles (PAMs)[205] and electro-conductive actuators are currently explored, to address 
this substantial challenge[206]. The materials of these actuators are usually silicone or 
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polyurethane based. Coating these devices with POSS-PCU may increase their 
biocompatibility and thus their ability to mimic normal human motion. 
In Chapter 5, the porogen size of 25-53 µm was chosen to do further characterisation 
because our previous study showed HBEC fell through the microporous POSS-PCU with the 
bigger porogen size (105-150 µm).  Regarding sterilisation techniques, there was a 
significant reduction in hydrophobicity by using ethanol rinsing, with changes in surface 
characteristics of the material, and subsequently increased protein adsorption and HBEC 
growth while the autoclave samples did not (as summarised in Figure 8.1). However, 
autoclaved POSS-PCU showed no significant change in mechanical properties compared to 
control. Therefore, the combination of the ethanol rinsing technique to activate the POSS-
PCU surface followed by steam sterilisation (autoclave) might be an ideal sterilisation 
sequence because the steam sterilisation is an acceptable standard for medical devices. 
 
Figure 8.1 Summary of optimisations on material for cell cultures 
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Controlling porosity is vital for balancing the need for vascularisation with biomechanical 
strength[207,208]. The results demonstrated greater control in reproducible porosity in 
microporous POSS-PCU manufacturing by incorporating the different amount of porogen 
(NaHCO3) to vary porosity. Higher %NaHCO3 generated a more porous structure at the 
outermost surface, and increased interconnected pores, as shown by water permeability 
testing. This supports the idea of using a microporous structure to coat the outside of the 
laryngeal framework and merits study of tissue integration or vascularisation in vivo. 
POSS-PCU previously has been tested and validated for cytocompatibility of different 
cell types such as dermal fibroblasts[135], chondrocytes[189], and endothelial cells[209]. In 
chapter 6, human bronchial epithelial cells (HBECs) were grown successfully on 
microporous POSS-PCU materials while maintaining epithelial cell markers. Additionally, 
the differentiated HBECs had all the expected characteristics such as layer stratification, 
intercellular tight-junction, mucin production and ciliation. This evidence suggested the 
growth and the differentiation of HBECs on POSS-PCU in vitro. The continuing work might 
be the measurement of cilia beating and investigation on other epithelial cell markers 
comparing with native airway tissue. This finding could also pave the way to use this 
material for other epithelial-derived conduits such as oesophagus and bile duct. Further work 
on improving epithelialisation of POSS-PCU conduits is required. The result showed that 
higher %NaHCO3 provides better cell migration and integration into microporous POSS-
PCU. The further investigation of using these materials in vivo (either polymer alone or in 
combination with an epithelial-sheet / decellularised tissue) is recommended. 
In chapter 7, microporous POSS-PCU showed cytocompatibility for human bone-marrow 
derived mesenchymal stem cells (BM-MSCs). BM-MSCs were grown and maintained on the 
material under in vitro condition over 35 days. BM-MSCs could also be differentiated to the 
chondrogenic lineage with a production of an ECM with some features of cartilage, 
composed of sGAG and collagen. The future challenge remains to studying this material 
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together with stem-cells to support cartilage replacement for laryngotracheal applications. 
The obtained pore size was around 25 – 53 µm and supported a good epithelial layer with in-
growth of cells (Chapter 6). A pore size range of 100 – 300 µm of other biomaterials, such as 
3D porous poly(epsilon-caprolactone) has been shown to support better chondrogenic or 
osteogenic differentiation of human BM-MSCs regarding integrated scaffold-matrix 
formation [197–199]. The future study of microporous POSS-PCU of similarly bigger pore 
size might be necessary to optimise the scaffold-cartilage formation. 
The results demonstrated the use of POSS-PCU materials in non-porous form and 
microporous foam-form, suitable for the design the 3D laryngeal frameworks with air-flow 
responsive voice function. Moreover, the prototype larynx proved to exhibit biomechanical 
characteristics similar to porcine laryngeal tissues, and surface enhancements accommodated 
HBECs growth and differentiation. This supports the possibility of developing POSS-PCU 
as a biomaterial for laryngotracheal tissue engineering, as well as other related applications.  
Having identified a promising biomaterial for airway tissue engineering, there are many 
steps before this can be applied in early phase clinical trials. More work is required to 
confirm biocompatibility in vivo, including the rate of tissue integration, neo-vascular 
formation, tissue fibrosis/stenosis, extrusion rate of the implants. If this work confirms the 
promise, standard operating procedures will be developed for clinical grade production, so 
that validated and reliable data that proves the new approach is ready for clinical trials in 
human patients. Good Laboratory Practice (GLP) studies in an appropriate large animal 
model will be used to generate safety, toxicity and potential efficacy data for a Medicines 
and Healthcare products Regulatory Agency (MHRA) and Clinical Trials Authorisation 
(CTA). In this way, the work herein will lead to the new generation of total-replacement 
laryngeal implants for patients in desperate need. 
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Appendix A 
The analyses of POSS leachate by ethanol rinse of casted and microporous (NaHCO3) 
POSS-PCU materials (BLL Reference : 09-0038-15 and 09-0039-15). 
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Appendix B 
Effect of sterilisation on HBEC’s viability and proliferation 
HBECs were seeded and grown on 30%, 50% and M70% NaHCO3 microporous POSS-
PCU using autoclave as a sterilisation technique. The results showed HBECs did not 
maintain their viability on material. In addition, the viability decreased over time course and 
were not significantly different from blank on day 11-14 (P > 0.05). This result supported 
the use of ethanol cleanse in in vitro culture experiments. 
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Appendix C 
Initial seeding density is crucial for observing the cell growth. Selecting the right density 
can help determine the optimal level of growth which is comparable between samples. The 
cell viability assay (alamarBlue®) was employed to determine in this step with different 
initial seeding densities of HBECs on 24-well TCP plate (5 X 10
3
, 1 X 10
4
, 5 X 10
4
, and 1 X 
10
5
 cells per well). 
The initial seeding of 1 X 10
5
 cells/well was probably too high because the cell grew fast 
from day 1 -11 and drop from day 11-14 which might be the death phase of the cell 
population. The initial seeding of 5 X 10
4
 cells/well exhibited the pattern covered much full 
range of growth phase during day 1 – 14. In addition, at day 14 the growth reached about the 
maximum and plateau out of growth level but not entered a dead phase. However, the initial 
seeding of 5 X 10
3
 and 1 X 10
4
 cells/well demonstrated the early growth phase with slow 
acceleration and did not reach the maximum point after 14 days. In conclusion, the 5 X 10
4
 
cells/well presented the optimal pattern of cell growth, reached the maximum growth at the 
end of observing time and had distinctive alamarBlue® measurement at each time points. 
This cell concentration was chosen for cell growth of in vitro experiment for both HBEC and 
BM-MSC on POSS-PCU materials. 
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Figure 1 Typical cell growth pattern, illustrating lag phase, growth phase, stationary 
phase and death phase. 
 
 
Figure 2 Growth pattern of HBECs over 14 days on TCP with different initial seeding 
densities.
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